MCID: MYL020
MIFTS: 51

Myelomeningocele

Categories: Fetal diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Myelomeningocele

MalaCards integrated aliases for Myelomeningocele:

Name: Myelomeningocele 12 52 58 54 3 15
Meningomyelocele 52 43 17

Characteristics:

Orphanet epidemiological data:

58
myelomeningocele
Inheritance: Multigenic/multifactorial,Not applicable; Age of onset: Infancy,Neonatal;

Classifications:

Orphanet: 58  
Rare neurological diseases
Developmental anomalies during embryogenesis


External Ids:

Disease Ontology 12 DOID:0060326
MeSH 43 D008591
SNOMED-CT 67 414667000 82058009
ICD10 32 Q05
UMLS via Orphanet 72 C0025312
Orphanet 58 ORPHA93969
UMLS 71 C0025312 C0086664 C0751316

Summaries for Myelomeningocele

NIH Rare Diseases : 52 Myelomeningocele is the most severe form of spina bifida . It happens when parts of the spinal cord and nerves come through the open part of the spine. It causes nerve damage and other disabilities. Seventy to ninety percent of children with this condition also have too much fluid on their brains (hydrocephalus ). This happens because fluid that protects the brain and spinal cord is unable to drain like it should. The fluid builds up, causing pressure and swelling. Without treatment, a person's head grows too big, and they may have brain damage. Other disorders of the spinal cord may be seen, including syringomyelia and hip dislocation. The cause of myelomeningocele is unknown. However, low levels of folic acid in a woman's body before and during early pregnancy is thought to play a part in this type of birth defect .

MalaCards based summary : Myelomeningocele, also known as meningomyelocele, is related to neural tube defects, folate-sensitive and tethered spinal cord syndrome. An important gene associated with Myelomeningocele is MTHFR (Methylenetetrahydrofolate Reductase), and among its related pathways/superpathways are Metabolism of water-soluble vitamins and cofactors and One carbon pool by folate. The drugs Oxybutynin and Darifenacin have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and skin, and related phenotypes are growth/size/body region and cardiovascular system

Disease Ontology : 12 A spina bifida characterized by protrusion of the spinal cord through an opening, covered by meningeal membranes.

CDC : 3 Spina bifida is a condition that affects the spine and is usually apparent at birth. It is a type of neural tube defect (NTD). Spina bifida can happen anywhere along the spine if the neural tube does not close all the way. When the neural tube doesn't close all the way, the backbone that protects the spinal cord doesn't form and close as it should. This often results in damage to the spinal cord and nerves. Spina bifida might cause physical and intellectual disabilities that range from mild to severe. The severity depends on: The size and location of the opening in the spine. Whether part of the spinal cord and nerves are affected.

Wikipedia : 74 Spina bifida is a birth defect in which there is incomplete closing of the spine and the membranes... more...

Related Diseases for Myelomeningocele

Diseases related to Myelomeningocele via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 403, show less)
# Related Disease Score Top Affiliating Genes
1 neural tube defects, folate-sensitive 32.2 MTRR MTR MTHFR MTHFD1
2 tethered spinal cord syndrome 30.8 VANGL1 MTHFD1
3 placental abruption 30.4 SLC19A1 MTRR MTHFR MTHFD1
4 strabismus 30.4 VANGL2 VANGL1 PRICKLE1 CELSR1
5 spina bifida occulta 30.4 VANGL2 VANGL1 MTHFR MTHFD1
6 ocular motility disease 30.2 VANGL2 VANGL1 CELSR1
7 omphalocele 30.1 SLC19A1 MTHFR MTHFD1
8 vitamin b12 deficiency 30.1 MTRR MTR MTHFR
9 homocysteinemia 29.8 SLC19A1 MTRR MTR MTHFR
10 cleft lip 29.6 SLC19A1 MTRR MTR MTHFR
11 down syndrome 29.3 SOD1 SLC19A1 MTRR MTR MTHFR
12 neural tube defects 28.0 VANGL2 VANGL1 TBXT SLC25A32 SLC19A1 SCRIB
13 anencephaly 28.0 VANGL2 VANGL1 TBXT SLC25A32 SCRIB PRICKLE1
14 chiari malformation type ii 11.8
15 chiari malformation 11.7
16 meningocele 11.7
17 schwartz cohen-addad lambert syndrome 11.6
18 ankyloblepharon filiforme imperforate anus 11.3
19 phaver syndrome 11.1
20 otopalatodigital syndrome, type ii 11.1
21 heterotaxy, visceral, 1, x-linked 11.1
22 chromosome 15q24 deletion syndrome 11.1
23 congenital laryngeal palsy 11.1
24 orofaciodigital syndrome 12 11.1
25 hydrocephalus 11.0
26 scoliosis 10.7
27 neurogenic bladder 10.7
28 isolated anencephaly 10.5 VANGL2 MTHFR
29 isolated exencephaly 10.5 VANGL2 MTHFR
30 hydrocephalus, congenital, 1 10.5
31 syringomyelia, noncommunicating isolated 10.5
32 vesicoureteral reflux 1 10.5
33 syringomyelia 10.5
34 methylmalonic aciduria and homocystinuria type cblg 10.4 MTRR MTR
35 homocystinuria due to deficiency of n -methylenetetrahydrofolate reductase activity 10.4 MTR MTHFR
36 nondisjunction 10.4 MTRR MTHFR
37 methylmalonic aciduria and homocystinuria type cble 10.4 MTRR MTR
38 spinal cord injury 10.4
39 paraplegia 10.4
40 spasticity 10.4
41 hydronephrosis 10.4
42 clubfoot 10.4
43 brachydactyly, type b1 10.4 VANGL2 VANGL1 PRICKLE1
44 constipation 10.4
45 acute cystitis 10.4
46 spina bifida aperta 10.3
47 choline deficiency disease 10.3 MTR MTHFR MTHFD1
48 homocystinuria 10.3 MTRR MTR MTHFR
49 vitamin metabolic disorder 10.3 MTRR MTR MTHFR
50 methylmalonic acidemia 10.3 MTRR MTR MTHFR
51 latex allergy 10.3
52 cerebrospinal fluid leak 10.3
53 hydromyelia 10.3
54 amino acid metabolic disorder 10.3 MTRR MTR MTHFR
55 neurogenic bowel 10.3
56 detrusor sphincter dyssynergia 10.2
57 oligohydramnios 10.2
58 cerebral palsy 10.2
59 diastematomyelia 10.2
60 craniorachischisis 10.2 VANGL2 SCRIB DACT1 CELSR1
61 phenylketonuria 10.2 MTRR MTR MTHFR
62 migraine with aura 10.2 MTRR MTR MTHFR
63 lipomatosis, multiple 10.2
64 preterm premature rupture of the membranes 10.2
65 pleomorphic lipoma 10.2
66 pyelonephritis 10.2
67 precocious puberty 10.2
68 megaloblastic anemia 10.2 MTRR MTR MTHFR MTHFD1
69 teratoma 10.2
70 congenital hydrocephalus 10.2
71 squamous cell carcinoma 10.2
72 pediatric osteosarcoma 10.2 SLC19A1 MTR MTHFR
73 marfan syndrome 10.2 MTRR MTR MTHFR
74 disorders of intracellular cobalamin metabolism 10.1 MTRR MTR
75 lipomyelomeningocele 10.1
76 osteomyelitis 10.1
77 syringohydromyelia 10.1
78 spina bifida cystica 10.1
79 childhood leukemia 10.1 SLC19A1 MTR MTHFR
80 total spina bifida aperta 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
81 cervicothoracic spina bifida aperta 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
82 vascular dementia 10.1 SOD1 NGF MTHFR
83 cervical spina bifida aperta 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
84 lumbosacral spina bifida aperta 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
85 thoracolumbosacral spina bifida aperta 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
86 upper thoracic spina bifida aperta 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
87 total spina bifida cystica 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
88 thoracolumbosacral spina bifida cystica 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
89 lumbosacral spina bifida cystica 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
90 sleep apnea 10.1
91 urolithiasis 10.1
92 mechanical strabismus 10.1
93 47,xyy 10.1
94 cervical spina bifida cystica 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
95 cervicothoracic spina bifida cystica 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
96 upper thoracic spina bifida cystica 10.1 VANGL2 VANGL1 TBXT MTHFR MTHFD1
97 orofacial cleft 10.1 PAX3 MTRR MTHFR MTHFD1
98 sacrococcygeal teratoma 10.1
99 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 10.0
100 thrombophilia due to thrombin defect 10.0
101 body mass index quantitative trait locus 11 10.0
102 body mass index quantitative trait locus 9 10.0
103 body mass index quantitative trait locus 8 10.0
104 body mass index quantitative trait locus 4 10.0
105 body mass index quantitative trait locus 10 10.0
106 body mass index quantitative trait locus 7 10.0
107 body mass index quantitative trait locus 12 10.0
108 body mass index quantitative trait locus 14 10.0
109 body mass index quantitative trait locus 18 10.0
110 body mass index quantitative trait locus 19 10.0
111 body mass index quantitative trait locus 20 10.0
112 chorioamnionitis 10.0
113 metabolic acidosis 10.0
114 sexual disorder 10.0
115 benign teratoma 10.0
116 intracranial hypertension 10.0
117 48,xyyy 10.0
118 encephalocele 10.0
119 growth hormone deficiency 10.0
120 hip subluxation 10.0
121 central nervous system malformation 10.0
122 methotrexate toxicity 10.0 SLC19A1 MTRR MTR MTHFR
123 epidermoid cysts 10.0
124 diaphragmatic hernia, congenital 10.0
125 attention deficit-hyperactivity disorder 10.0
126 ige responsiveness, atopic 10.0
127 spinal arachnoiditis 10.0
128 hydrocephalus due to congenital stenosis of aqueduct of sylvius 10.0
129 exstrophy of bladder 10.0
130 branchiootic syndrome 1 10.0
131 cyanosis, transient neonatal 10.0
132 alkuraya-kucinskas syndrome 10.0
133 pulmonary hypertension 10.0
134 klippel-feil syndrome 10.0
135 microcephaly 10.0
136 pulmonary edema 10.0
137 low compliance bladder 10.0
138 arachnoiditis 10.0
139 cystic teratoma 10.0
140 hypertrichosis 10.0
141 holoprosencephaly 10.0
142 mature teratoma 10.0
143 placenta disease 10.0
144 peritonitis 10.0
145 chromosomal triplication 10.0
146 spinal shock 10.0
147 myelocystocele 10.0
148 congenital amyoplasia 10.0
149 osteoporosis 10.0
150 bone mineral density quantitative trait locus 8 10.0
151 bone mineral density quantitative trait locus 15 10.0
152 neonatal meningitis 10.0
153 congenital anomalies of kidney and urinary tract 2 9.9
154 digeorge syndrome 9.9
155 cryptorchidism, unilateral or bilateral 9.9
156 enterocolitis 9.9
157 gastroschisis 9.9
158 focal dermal hypoplasia 9.9
159 ataxia and polyneuropathy, adult-onset 9.9
160 pain agnosia 9.9
161 cardiac arrest 9.9
162 monocular esotropia 9.9
163 rickets 9.9
164 respiratory failure 9.9
165 visual epilepsy 9.9
166 inflammatory spondylopathy 9.9
167 bacteriuria 9.9
168 hypothyroidism 9.9
169 craniosynostosis 9.9
170 cranial nerve palsy 9.9
171 urinary tract obstruction 9.9
172 spondylitis 9.9
173 end stage renal disease 9.9
174 lung disease 9.9
175 perinatal necrotizing enterocolitis 9.9
176 learning disability 9.9
177 waardenburg's syndrome 9.9
178 meningitis 9.9
179 pathologic nystagmus 9.9
180 esotropia 9.9
181 abdominal wall defect 9.9
182 autonomic dysfunction 9.9
183 back pain 9.9
184 chronic pain 9.9
185 dysphagia 9.9
186 seizure disorder 9.9
187 neurenteric cyst 9.9
188 overgrowth syndrome 9.9
189 parachordoma 9.9 TBXT GFAP
190 waardenburg syndrome, type 4b 9.9 PAX3 DACT1
191 prune belly syndrome 9.8
192 aortic valve disease 1 9.8
193 cri-du-chat syndrome 9.8
194 epicanthus 9.8
195 pelvic organ prolapse 9.8
196 velocardiofacial syndrome 9.8
197 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.8
198 agnathia-otocephaly complex 9.8
199 right atrial isomerism 9.8
200 oeis complex 9.8
201 thoracoabdominal syndrome 9.8
202 sacral defect with anterior meningocele 9.8
203 resting heart rate, variation in 9.8
204 patent ductus arteriosus 1 9.8
205 caudal duplication anomaly 9.8
206 apraxia 9.8
207 umbilical hernia 9.8
208 cerebellar hypoplasia 9.8
209 venous insufficiency 9.8
210 suppression amblyopia 9.8
211 amblyopia 9.8
212 alternating exotropia 9.8
213 exotropia 9.8
214 cascade stomach 9.8
215 patent foramen ovale 9.8
216 atrial heart septal defect 9.8
217 encephalomalacia 9.8
218 rhabdomyosarcoma 9.8
219 cellulitis 9.8
220 bladder disease 9.8
221 verrucous carcinoma 9.8
222 poliomyelitis 9.8
223 situs inversus 9.8
224 ileus 9.8
225 neurofibromatosis 9.8
226 hemorrhoid 9.8
227 hypoplastic left heart syndrome 9.8
228 haemophilus influenzae 9.8
229 meningoencephalocele 9.8
230 penoscrotal transposition 9.8
231 sacral meningocele conotruncal heart defects 9.8
232 sirenomelia 9.8
233 wandering spleen 9.8
234 cleft lip/palate 9.8
235 occipital encephalocele 9.8
236 ectopia cordis 9.8
237 pik3ca-related overgrowth syndrome 9.8
238 lobar holoprosencephaly 9.8
239 atrial standstill 1 9.7
240 gastroesophageal reflux 9.7
241 cleft palate, isolated 9.7
242 coloboma of macula 9.7
243 multiple sclerosis 9.7
244 exudative vitreoretinopathy 1 9.7
245 fibrosis of extraocular muscles, congenital, 1 9.7
246 hair whorl 9.7
247 hand skill, relative 9.7
248 hypertelorism 9.7
249 intussusception 9.7
250 waardenburg syndrome, type 3 9.7
251 larsen syndrome 9.7
252 laryngomalacia 9.7
253 legg-calve-perthes disease 9.7
254 optic nerve hypoplasia, bilateral 9.7
255 poland syndrome 9.7
256 currarino syndrome 9.7
257 dowling-degos disease 1 9.7
258 spondylolisthesis 9.7
259 tetralogy of fallot 9.7
260 renal hypodysplasia/aplasia 1 9.7
261 vertical talus, congenital 9.7
262 volvulus of midgut 9.7
263 waardenburg syndrome, type 1 9.7
264 lipoid congenital adrenal hyperplasia 9.7
265 anus, imperforate 9.7
266 arachnoid cysts, intracranial 9.7
267 chordoma 9.7
268 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.7
269 corpus callosum, agenesis of 9.7
270 cystic fibrosis 9.7
271 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.7
272 methane production 9.7
273 3-methylglutaconic aciduria, type iii 9.7
274 peters-plus syndrome 9.7
275 insulin-like growth factor i 9.7
276 tibial hemimelia 9.7
277 corpus callosum, partial agenesis of, x-linked 9.7
278 muscular dystrophy, duchenne type 9.7
279 kearns-sayre syndrome 9.7
280 glycine encephalopathy 9.7
281 meningioma, radiation-induced 9.7
282 body mass index quantitative trait locus 1 9.7
283 gastrointestinal stromal tumor 9.7
284 meningioma, familial 9.7
285 spondylocostal dysostosis 3, autosomal recessive 9.7
286 leukemia, acute lymphoblastic 3 9.7
287 corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia 9.7
288 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.7
289 polymicrogyria with or without vascular-type ehlers-danlos syndrome 9.7
290 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.7
291 cortical dysplasia, complex, with other brain malformations 10 9.7
292 congenital hypothyroidism 9.7
293 arrhythmogenic right ventricular cardiomyopathy 9.7
294 tooth agenesis 9.7
295 spastic cerebral palsy 9.7
296 atrioventricular block 9.7
297 third-degree atrioventricular block 9.7
298 idiopathic scoliosis 9.7
299 sclerocornea 9.7
300 porencephaly 9.7
301 ectopic pregnancy 9.7
302 thrombosis 9.7
303 obstructive nephropathy 9.7
304 osteonecrosis 9.7
305 brown's tendon sheath syndrome 9.7
306 pre-eclampsia 9.7
307 short bowel syndrome 9.7
308 hemiplegia 9.7
309 arteriovenous malformation 9.7
310 spinal meningioma 9.7
311 patau syndrome 9.7
312 gestational diabetes 9.7
313 nephrotic syndrome 9.7
314 corneal staphyloma 9.7
315 cardiovascular system disease 9.7
316 spinal cord lipoma 9.7
317 facial paralysis 9.7
318 toxic shock syndrome 9.7
319 obstructive hydrocephalus 9.7
320 frozen shoulder 9.7
321 renal tubular acidosis 9.7
322 neurogenic arthropathy 9.7
323 urticaria 9.7
324 normal pressure hydrocephalus 9.7
325 ventricular septal defect 9.7
326 cystitis 9.7
327 heart septal defect 9.7
328 epilepsy 9.7
329 impotence 9.7
330 malignant fibrous histiocytoma 9.7
331 dysostosis 9.7
332 ankylosis 9.7
333 hidradenitis suppurativa 9.7
334 hidradenitis 9.7
335 spondylolysis 9.7
336 thrombophilia 9.7
337 hemangioma 9.7
338 bursitis 9.7
339 glioblastoma multiforme 9.7
340 gingivitis 9.7
341 lipomatosis 9.7
342 central nervous system disease 9.7
343 histiocytosis 9.7
344 arthropathy 9.7
345 fibrous histiocytoma 9.7
346 secretory meningioma 9.7
347 lymphoplasmacyte-rich meningioma 9.7
348 mongolian spot 9.7
349 cervicomedullary junction neoplasm 9.7
350 pleomorphic xanthoastrocytoma 9.7
351 elephantiasis 9.7
352 ureteral obstruction 9.7
353 infertility 9.7
354 sleep disorder 9.7
355 internuclear ophthalmoplegia 9.7
356 kidney disease 9.7
357 acute pyelonephritis 9.7
358 nephrolithiasis 9.7
359 agoraphobia 9.7
360 compartment syndrome 9.7
361 lumbosacral lipoma 9.7
362 muscular atrophy 9.7
363 chronic kidney disease 9.7
364 intestinal obstruction 9.7
365 malignant hyperthermia 9.7
366 nervous system disease 9.7
367 decubitus ulcer 9.7
368 miliary tuberculosis 9.7
369 muscular dystrophy 9.7
370 albinism 9.7
371 polymicrogyria 9.7
372 bronchopulmonary dysplasia 9.7
373 chromosome 10q duplication 9.7
374 colpocephaly 9.7
375 dwarfism 9.7
376 fetal aminopterin syndrome 9.7
377 horseshoe kidney 9.7
378 oligoastrocytoma 9.7
379 periodontal ehlers-danlos syndrome 9.7
380 posterior urethral valves 9.7
381 skeletal dysplasias 9.7
382 triploidy 9.7
383 tuberculous meningitis 9.7
384 central precocious puberty 9.7
385 anoxia 9.7
386 hypertonia 9.7
387 hypotonia 9.7
388 myoclonus 9.7
389 neuronal migration disorders 9.7
390 paresthesia 9.7
391 swallowing disorders 9.7
392 epignathus 9.7
393 hemimelia 9.7
394 diprosopus 9.7
395 ependymoblastoma 9.7 NGF GFAP
396 physical disorder 9.7 VANGL2 VANGL1 PAX3 MTRR MTR MTHFR
397 spindle cell rhabdomyosarcoma 9.7 PAX3 GFAP
398 spastic paraplegia 38, autosomal dominant 9.7 SOD1 GFAP
399 toxic encephalopathy 9.6 SOD1 NGF GFAP
400 pick disease of brain 9.5 SOD1 NGF GFAP
401 chronic wasting disease 9.5 SOD1 GFAP
402 autism spectrum disorder 9.3 SOD1 MTRR MTR MTHFR GFAP
403 folate malabsorption, hereditary 9.1 SLC25A32 SLC19A1 FOLR3 FOLR2 FOLR1

Graphical network of the top 20 diseases related to Myelomeningocele:



Diseases related to Myelomeningocele

Symptoms & Phenotypes for Myelomeningocele

MGI Mouse Phenotypes related to Myelomeningocele:

45 (showing 15, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.4 CELSR1 DACT1 FOLR1 GFAP MTHFD1 MTHFR
2 cardiovascular system MP:0005385 10.33 DACT1 FOLR1 GFAP MTHFD1 NGF PAX3
3 mortality/aging MP:0010768 10.33 CELSR1 DACT1 FOLR1 GFAP MTHFD1 MTHFR
4 embryo MP:0005380 10.29 CELSR1 DACT1 FOLR1 MTHFD1 PAX3 PRICKLE1
5 nervous system MP:0003631 10.24 CELSR1 DACT1 FOLR1 GFAP MTHFD1 MTHFR
6 digestive/alimentary MP:0005381 10.18 DACT1 FOLR1 GFAP PAX3 PRICKLE1 SCRIB
7 limbs/digits/tail MP:0005371 10.17 CELSR1 DACT1 FOLR1 MTHFD1 MTHFR PAX3
8 integument MP:0010771 10.16 CELSR1 FOLR1 MTHFR NGF PAX3 PRICKLE1
9 craniofacial MP:0005382 10.14 CELSR1 FOLR1 PAX3 PRICKLE1 SCRIB SLC25A32
10 hearing/vestibular/ear MP:0005377 10.08 CELSR1 FOLR1 PAX3 PRICKLE1 SCRIB SOD1
11 no phenotypic analysis MP:0003012 9.92 DACT1 MTHFR NGF PAX3 PRICKLE1 SCRIB
12 renal/urinary system MP:0005367 9.86 DACT1 FOLR1 PAX3 PRICKLE1 SCRIB SLC19A1
13 reproductive system MP:0005389 9.85 CELSR1 DACT1 FOLR1 MTHFR SCRIB SLC19A1
14 skeleton MP:0005390 9.65 CELSR1 DACT1 MTHFR PAX3 PRICKLE1 SCRIB
15 vision/eye MP:0005391 9.32 CELSR1 FOLR1 GFAP MTHFR NGF PAX3

Drugs & Therapeutics for Myelomeningocele

Drugs for Myelomeningocele (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 28, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Oxybutynin Approved, Investigational Phase 4 5633-20-5 4634
2
Darifenacin Approved, Investigational Phase 2 133099-04-4 444031
3 Neurotransmitter Agents Phase 2
4 Cholinergic Agents Phase 2
5 Muscarinic Antagonists Phase 2
6 Cholinergic Antagonists Phase 2
7
Methenamine Approved, Vet_approved Phase 1 100-97-0 4101
8
Mycophenolic acid Approved Phase 1 24280-93-1 446541
9 Acidophilus Phase 1
10 Methenamine mandelate Phase 1
11 Methenamine hippurate Phase 1
12 Antitubercular Agents Phase 1
13 Anti-Infective Agents Phase 1
14 Anti-Bacterial Agents Phase 1
15 Antibiotics, Antitubercular Phase 1
16
Nitrous oxide Approved, Vet_approved 10024-97-2 948
17
Acetylcholine Approved, Investigational 51-84-3 187
18
tannic acid Approved 1401-55-4
19
Benzocaine Approved, Investigational 94-09-7, 1994-09-7 2337
20
Imidacloprid Vet_approved 105827-78-9 86418
21 abobotulinumtoxinA
22 Botulinum Toxins
23 Botulinum Toxins, Type A
24 Cola
25 Anesthetics
26 Pharmaceutical Solutions
27 Calamus
28 glucocorticoids

Interventional clinical trials:

(showing 51, show less)
# Name Status NCT ID Phase Drugs
1 Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele Unknown status NCT00175123 Phase 4 Botulinum A toxin
2 A 14-day, Open-label, Multicenter, Dose-escalating, Sequential Cohort Study to Evaluate Pharmacodynamics (Urodynamics) and Pharmacokinetics, Clinical Efficacy, Tolerability and Safety, Following Multiple Doses (mg/kg/Day) of Darifenacin Liquid Oral Suspension Given b.i.d. (Twice Daily) in Children, Ages 2 - 15 Years, With Neurogenic Detrusor Overactivity Terminated NCT00712322 Phase 2 Darifenacin;Darifenacin;Darifenacin;Darifenacin
3 Bacteriuria Eradication Through Probiotics Unknown status NCT00717600 Phase 1
4 Pilot Study of Mycophenolate Mofetil in Congenital Uropathies Completed NCT00193635 Phase 1 mycophenolate mofetil
5 Study to Compare 2 Minimally Invasive Fetal Neural Tube Defect Repair Techniques: Repair Using Durepair Patch vs. Repair Without Durepair Patch Recruiting NCT03794011 Phase 1
6 Minimally Invasive Fetal Neural Tube Defect Repair Study Active, not recruiting NCT02230072 Phase 1
7 Changes in the Cuff Pressure in Infants in the Absence of Nitrous Oxide Unknown status NCT03088761
8 Open Spina Bifida Fetoscopic Repair Project Unknown status NCT03562286
9 NSC Assistive Technology Research: Reciprocating Gait Orthoses for Paraplegia Patients Unknown status NCT02227407
10 In Vivo Comparison of Air Charged Catheters With Water Filled Catheters for Intravesical and Intrarectal Pressures Recording During Urodynamic Study Unknown status NCT02030340
11 Effectiveness of Prophylaxis of Urinary Tract Infections in Children With a Probiotic Containing Lactobacillus Rhamnosus PL1 and Lactobacillus Plantarum PM1, a Randomised Clinical Trial Unknown status NCT03462160
12 Daily Physical Activity in Children and Adolescents With Low Lumbar and Sacral Level Myelomeningocele Completed NCT04186338
13 Impact of Prenatal Correction of Spina Bifida Using Fetoscopy and the SAFER Technique on Long-term Neurodevelopment. Completed NCT04356703
14 Can Dynamic Ultrasonography Replace Urodynamics in the Follow-up of Patients With Myelomeningocele: A Prospective Concurrent Study Completed NCT03550898
15 Efficacy Of Pulsed Electromagnetic Field Therapy On Neurogenic Bladder in Children With Myelomeningocele Completed NCT04187027
16 Myelomeningocele Repair Randomized Trial Completed NCT00060606
17 Risk Factors Associated With Spontaneous Preterm Delivery Status Post Open Fetal Myelomeningocele Repair Completed NCT03073382
18 Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions Completed NCT01208584
19 Reliability of the Melbourne Assessment Completed NCT02595411
20 Feasibility of a Home-based Interactive System for Upper Limb Therapy (YouGrabber) Completed NCT02368223
21 Retrospective Study With Botulinic Toxin in Neurogenic Detrusor Overactivity Completed NCT03042052 detrusor infection of Botulinum toxin
22 An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience Completed NCT03544970
23 Retrograde Colonic Irrigation to Manage Spina Bifida Functional Digestive Sequelae: a Multicenter, Prospective, Randomized Controlled Trial Completed NCT02361450
24 A Three-year Behavioral Treatment of Obese Children: the Effect of Age on Change in BMI SDS and Dropout Rate Completed NCT01029964
25 New Protocol for Identification of Serious Bacterial Infection in Febrile Newborn Completed NCT03183531
26 In Utero Endoscopic Correction of Myelomeningocele: Laparotomy Versus Percutaneous - A Pilot Study Recruiting NCT03856034
27 Extended Criteria For Fetal Myelomeningocele Repair: A Pilot Study Recruiting NCT02664207
28 Sleep-disordered Breathing in Infants With Myelomeningocele Recruiting NCT04251806
29 Early Feasibility Study of Fetoscopic Myelomeningocele Repair Using a Cryopreserved Human Umbilical Cord Allograft (NEOX Cord 1K®) as a Meningeal Patch Recruiting NCT04243889
30 Prenatal Endoscopic Repair of Fetal Spina Bifida Recruiting NCT02390895
31 Long Term Assessment and Outcome of Adult Patients With Congenital Genitourinary Abnormalities. Recruiting NCT03061084
32 Fetal Endoscopic Surgery for Spina Bifida Recruiting NCT03315637
33 Epigenetic Alterations in Stress Regulation Genes Among Newborns After Fetal Surgery for Myelomeningocele Repair: An Exploratory Study Recruiting NCT04027374
34 Qualitative In-depth Interviews With Women and Their Partners Concerning the Acceptability of Fetal Surgery Recruiting NCT03788122
35 Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida Recruiting NCT03090633
36 In-Utero Endoscopic Correction of Spina Bifida: Laparotomy or Percutaneous Recruiting NCT04362592
37 Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Nocturnal Enuresis in Children Recruiting NCT04313192
38 Comparative Study in the Clinical Efficacy, Satisfaction and Complications While Treating Walking Spica Cast vs Synthetic Pants in the Management of Pediatric Low-energy Femoral Shaft Fracture. Randomized Clinical Trial Recruiting NCT04311866
39 Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children Recruiting NCT02900495
40 Prenatal Surgical Repair of Fetal Myelomeningocele Active, not recruiting NCT01983345
41 Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study Enrolling by invitation NCT03936322
42 Telemedicine in Spina Bifida Transition: A Pilot Study Enrolling by invitation NCT03466996
43 EVALUATION OF THE SENSORY-MOTOR RESPONSE IN PATIENTS WITH MYELOMENINGOCELE FOLLOWING TREATMENT WITH PHOTOBIOMODULATION Not yet recruiting NCT04035863
44 The Effects of Physical Therapy Associated With Photobiomodulation on Functional Performance in Children With Low Lumbar and Sacral Myelomeningocele - A Randomized, Blinded Clinical Trial. Not yet recruiting NCT04425330
45 A Patient-centered Approach to Urinary Incontinence and Quality of Life in Children and Adolescents With Spina Bifida Not yet recruiting NCT03410667
46 Case Control Study to Investigate the Use of Urethral Pressure Profile Measurement in Children Not yet recruiting NCT04147793
47 Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0 Terminated NCT02509377
48 Evaluation of Hysterotomy Site After Open Fetal Surgery Terminated NCT02493062
49 Open Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 And 40.0 Terminated NCT03044821
50 Prospective Randomized Controlled Trial Comparing Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer. Terminated NCT01751503
51 Magnetic Resonance Imaging of the Spine Withdrawn NCT01382290

Search NIH Clinical Center for Myelomeningocele

Cochrane evidence based reviews: meningomyelocele

Genetic Tests for Myelomeningocele

Anatomical Context for Myelomeningocele

MalaCards organs/tissues related to Myelomeningocele:

40
Spinal Cord, Brain, Skin, Bone, Testes, Colon, Kidney

Publications for Myelomeningocele

Articles related to Myelomeningocele:

(showing 4397, show less)
# Title Authors PMID Year
1
Homocysteine, folate, lipid profile and MTHFR genotype and disability in children with myelomeningocele. 54 61
16602021 2006
2
Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. 54 61
17035141 2006
3
MTHFR 677 TT genotype in a mother and her child with Down syndrome, atrioventricular canal and exstrophy of the bladder: implications of a mutual genetic risk factor? 54 61
16602006 2006
4
No evidence for heterozygote advantage at MTHFR in patients with lumbosacral myelomeningocele or their relatives. 61 54
14726815 2004
5
The effect of C677T mutation of methylene tetrahydrofolate reductase gene and plasma folate level on hyperhomocysteinemia in patients with meningomyelocele. 61 54
11048629 2000
6
Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. 61 54
10517251 1999
7
Myelomeningocele and Waardenburg syndrome (type 3) in patients with interstitial deletions of 2q35 and the PAX3 gene: possible digenic inheritance of a neural tube defect. 61 54
9482647 1998
8
Improved Coverage of Mouse Myelomeningocele With a Mussel Inspired Reverse Thermal Gel. 61
32197182 2020
9
Retrieving the Moral in the Ethics of Maternal-Fetal Surgery. 61
32484133 2020
10
Factors Associated With Ambulation in Myelomeningocele: A Longitudinal Study From the National Spina Bifida Patient Registry. 61
32209832 2020
11
Brain abnormalities in myelomeningocele patients. 61
31664560 2020
12
How we measure and determine competence: lessons from fetal myelomeningocele repair. 61
32478981 2020
13
Myelomeningocele sac associated with worse lower-extremity neurological sequelae: evidence for prenatal neural stretch injury? 61
31613408 2020
14
Intrauterine total percutaneous fetoscopic repair of myelomeningocele: 30 months follow up data. 61
32510722 2020
15
Response to Letter to the Editor re 'Fetal repair of myelomeningocele: Current status and urologic implications'. 61
32513443 2020
16
RE: Clayton DB, Thomas JC, Brock III JW. Fetal repair of myelomeningocele: Current status and urologic implications. 61
32517969 2020
17
Lung destruction secondary to intrapulmonary migration of a ventriculoperitoneal shunt catheter: report of an unusual case and literature review. 61
32514761 2020
18
Long term continuation with repeated Botulinum toxin A injections in people with neurogenic detrusor overactivity after spinal cord injury. 61
31913344 2020
19
First experience with ATOMS system implant in neurogenic stress urinary incontinence. 61
32542976 2020
20
Learning curves of open and endoscopic fetal spina bifida closure: systematic review and meta-analysis. 61
31273862 2020
21
Neuraxial dysraphism in EPAS1-associated syndrome due to improper mesenchymal transition. 61
32337341 2020
22
Fetal anesthesia: intrauterine therapies and immediate postnatal anesthesia for noncardiac surgical interventions. 61
32324666 2020
23
The value of preoperative labs in identifying "at-risk" patients for developing surgical site infections after pediatric neuromuscular spine deformity surgery. 61
31925757 2020
24
Detailed Analysis of Hydrocephalus and Hindbrain Herniation After Prenatal and Postnatal Myelomeningocele Closure: Report From a Single Institution. 61
31432079 2020
25
The incidence and effect of tethered cord release for tethered cord syndrome in patients with myelomeningocele: a population-based study. 61
32470933 2020
26
Factors Associated with Early Neonatal and First-Year Mortality in Infants with Myelomeningocele in California from 2006 to 2011. 61
32473597 2020
27
Myelomeningocele Repair Combining a Double Cryopreserved Amniotic Membrane Homograft and the Keystone Flap in a 3-Year-Old Child: A Case Report. 61
32454485 2020
28
The Keystone Island Perforator Flap in Reconstruction of Large Myelomeningocele Defects. 61
31503022 2020
29
Letter to the Editor. The fallacy of sunk cost: decision-making after intrauterine myelomeningocele repair. 61
32384270 2020
30
Botulinum Toxin Type A Therapy: Intravesical Injection or Electromotive Drug Administration. 61
32437774 2020
31
Neonatal ten-year retrospective study on neural tube defects in a second level University Hospital. 61
32448340 2020
32
Maternal low body mass index is a risk factor for fetal ductal constriction following indomethacin use among women undergoing fetal repair of spina bifida. 61
32003478 2020
33
Symptomatic Recurrence of Cervical Spine Myelomeningocele in an Adult Patient. 61
32109641 2020
34
Enlargement of Extraspinal Cysts in Spinal Dysraphism : A Reason for Early Untethering. 61
32336061 2020
35
Tocolysis for open prenatal repair of myelomeningocele: systematic review. 61
30526147 2020
36
Keystone flap: a safe coverage option in the handling of salvage for myelomeningocele. 61
32468239 2020
37
Surgical management of Chiari malformation type II. 61
32474814 2020
38
Ruptured dermoid cyst of the conus medullaris in the myelomeningocele sac revealed at the initial repair surgery. 61
31776717 2020
39
Cerebrospinal fluid alterations following endoscopic third ventriculostomy with choroid plexus cauterization: a retrospective laboratory analysis of two tertiary care centers. 61
31781913 2020
40
Utilization of Augmentation Cystoplasty for Myelomeningocele Patients Remained Stable Over the Past Decade. 61
32360629 2020
41
Non-surgical intervention for open myelomeningocele in an infant with trisomy 18. 61
32212200 2020
42
Severe and progressive neuronal loss in myelomeningocele begins before 16 weeks of pregnancy. 61
32283072 2020
43
Abnormal anisotropic diffusion properties in pediatric myelomeningocele patients treated with fetal surgery: an initial DTI study. 61
31399765 2020
44
Hindbrain Herniation and Banana and Lemon Sign After Open Fetal Myelomeningocele Repair - When Do These Signs Disappear and is Shunting Predictable? 61
32330995 2020
45
Histological response and expression of collagen, metalloproteinases MMP-1 and MMP-9 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in fetal membranes following open intrauterine surgery: an experimental study. 61
32295446 2020
46
Alterations in skull base anatomy in intrauterine and postnatal repaired myelomeningoceles. 61
32239293 2020
47
Fetal surgery and stem cell therapy for meningomyelocele. 61
32004173 2020
48
A new approach for spinal deformity patients with meningomyelocele: reverse Y incision. 61
32301344 2020
49
Fetal surgical intervention for myelomeningocele: lessons learned, outcomes, and future implications. 61
31840814 2020
50
Relationships among classifications of impairment and measures of ambulatory function for children with spina bifida. 61
32255380 2020
51
Interrater Reliability of the Pediatric Neuromuscular Recovery Scale in Children with Spina Bifida. 61
31012779 2020
52
Suture techniques and patch materials using an in-vitro model for watertight closure of in-utero spina bifida repair. 61
31255327 2020
53
Long-Term Intellectual and Fine Motor Outcomes in Spina Bifida Are Related to Myelomeningocele Repair and Shunt Intervention History. 61
31729310 2020
54
Uterovaginal Prolapse in a Newborn with Meningomyelocele: Case Report. 61
32304858 2020
55
Multiple Neural Tube Defects: A Case Report. 61
32350236 2020
56
Spontaneous closure of myelomeningocele. 61
32025870 2020
57
In Utero Restoration of Hindbrain Herniation in Fetal Myelomeningocele as Part of Prenatal Regenerative Therapy Program at Mayo Clinic. 61
32247347 2020
58
Dynamic mapping of the corticospinal tract in open cordotomy and myelomeningocele surgery. 61
31973921 2020
59
Endoscopic third ventriculostomy in patients with myelomeningocele after shunt failure. 61
32248278 2020
60
Study of Lethal Congenital Malformations at a Tertiary-Care Referral Centre in North India. 61
32373406 2020
61
A Simplified Approach to Myelomeningocele Defect Repair. 61
32349084 2020
62
Anterior Myelomeningocele Without Neurospinal Involvement: A Rare Posterior Mediastinal Disorder. 61
31472139 2020
63
Relationship between Movement Quality, Functional Ambulation Status, and Spatiotemporal Gait Parameters in Children with Myelomeningocele. 61
32138581 2020
64
Ambulation, lesion level, and health-related quality of life in children with myelomeningocele. 61
31423555 2020
65
Anesthesia management during meningomyelocele repair alongside motor-evoked potentials in a newborn and a small infant. 61
32221655 2020
66
Meningocele tourniquet syndrome. 61
32172393 2020
67
The Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid Following Intravenous Administration: A Report of Successfully Treated Infant with Mycoplasma hominis Meningitis. 61
32195773 2020
68
Surgical intervention for hydrocephalus in infancy; etiology, age and treatment data in a Dutch cohort. 61
31407034 2020
69
Risk factors, presentation and outcome of meningomyelocele repair. 61
32292446 2020
70
Fetal therapies as standard prenatal care in Japan. 61
32206649 2020
71
Heritable spina bifida in sheep: A potential model for fetal repair of myelomeningocele. 61
31301886 2020
72
Prenatal diagnosis of closed spina bifida: multicenter case series and review of the literature. 61
30001658 2020
73
In utero myelomeningocele repair reduces intensification of inflammatory changes in the dura mater and the skin. 61
32223587 2020
74
Predictors of Walking Activity in Children and Adolescents With Myelomeningocele. 61
31778661 2020
75
Klippel-Feil Syndrome With Auxiliary Anterior Cervical Meningomyelocele and Thoracic Syringomyelia: A Case Report. 61
30028777 2020
76
Prenatal counseling for myelomeningocele in the era of fetal surgery: a shared decision-making approach. 61
32109872 2020
77
Improved Postoperative Metrics with Modified Myofascial Closure in Fetal Myelomeningocele Repair. 61
31222267 2020
78
Need for botulinum toxin injection and bladder augmentation after isolated bladder outlet procedure in pediatric patients with myelomeningocele. 61
31839471 2020
79
An Open Fetal Myelomeningocele Repair With Incorporation of a Skin Allograft. 61
31289012 2020
80
Prenatal Repair of Myelomeningocele and School-age Functional Outcomes. 61
31980545 2020
81
Fetal repair of myelomeningocele: current status and urologic implications. 61
31902678 2020
82
Antibiotic Prophylaxis Prescribing Patterns of Pediatric Urologists for Children with Vesicoureteral Reflux and other Congenital Anomalies of the Kidney and Urinary Tract. 61
31758980 2020
83
Luckenschadel Associated with Chiari Type II Malformation: An Autopsy Case Report. 61
32096430 2020
84
New insights in cerebral findings associated with fetal myelomeningocele: a retrospective cohort study in a single tertiary centre. 61
32112473 2020
85
Open Intrauterine Fetal Myelomeningocele Repair: Changes in the Surgical Procedure and Perinatal Complications during the First 8 Years of Experience at a Single Center. 61
31801139 2020
86
Postoperative imaging following fetal open myelomeningocele repair: The clinical utility of magnetic resonance imaging and sonographic amniotic fluid volumes in detecting suspected hysterotomy scar dehiscence. 61
31600420 2020
87
A Decade of Experience with the Ovine Model of Myelomeningocele: Risk Factors for Fetal Loss. 61
32097922 2020
88
Does Kyphectomy Improve the Quality of Life of Patients With Myelomeningocele? 61
31567706 2020
89
CORR Insights®: Does Kyphectomy Improve the Quality of Life of Patients With Myelomeningocele? 61
31764316 2020
90
Evaluation and Disposition of Fetal Myelomeningocele Repair Candidates: A Large Referral Center Experience. 61
31212296 2020
91
Amylase concentration and activity in the amniotic fluid of fetal rats with retinoic acid induced myelomeningocele. 61
31910702 2020
92
The Association between the Timing of Shunt Placement and Shunt Infection in Hydrocephalus Associated with Myelomeningocele. 61
31452179 2020
93
Comparison of two different methods in preoperative planning of the amount of lengthening in Z achilloplasty technique. 61
31425334 2020
94
Triple Use of Autologous Amnion Graft in the Treatment of Meningomyelocele and Split Cord Malformation. 61
32095387 2020
95
The growth of pediatric neurosurgery in southern Vietnam and the first separation of pygopagus twins: case report. 61
31952040 2020
96
Postoperative cardiorespiratory arrest in a case of cervical meningocele. 61
32257571 2020
97
Use of an abdominal reapproximation anchor system in the closure of large, open myelomeningoceles. 61
31978887 2020
98
Bilateral Bochdalek Hernias Associated with Arnold-Chiari I Malformation. 61
32047696 2020
99
Fetal spina bifida in a pregnant woman following omega gastric bypass: Case report and literature review. 61
32417729 2020
100
Timing of Shunt Insertion in Children with Neural Tube Defects and Hydrocephalus: A Clinical Study. 61
32153000 2020
101
Multiple Congenital Anomalies in a Patient with Interstitial 6q26 Deletion. 61
32021599 2020
102
Surgical outcomes of six bulldogs with spinal lumbosacral meningomyelocele or meningocele. 61
31758707 2020
103
Benchmarking against the MOMS Trial: Zurich Results of Open Fetal Surgery for Spina Bifida. 61
31167195 2020
104
In utero Hepatitis B Immunization during Fetal Surgery for Spina Bifida. 61
31722359 2020
105
Comparison of brain microstructure after prenatal spina bifida repair by either laparotomy-assisted fetoscopic or open approach. 61
31219638 2020
106
A Comparative Analysis of Bladder Pattern of Patients who Underwent In Utero Versus Postnatal Myelomeningocele Repair. 61
31479395 2020
107
Complex Fetal Care Cases: Fetoscopic Myelomeningocele Repair. 61
31894087 2020
108
Risk Factors for Preterm Birth following Open Fetal Myelomeningocele Repair: Results from a Prospective Cohort. 61
31104051 2020
109
Open fetal surgery for myelomeningocele - is there the learning curve at reduction mother and fetal morbidity? 61
32266952 2020
110
ABO and Rh Blood Groups and Risk of Myelomeningocele. 61
32239487 2020
111
Featuring: urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty. 61
31931972 2019
112
Two cases of hidradenitis suppurativa exacerbated by ambulatory aides for myelomeningocele. 61
31788527 2019
113
Commentary: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele: Executive Summary. 61
31728543 2019
114
Evaluation and Long-term Management of Neurogenic Bladder in Spinal Dysraphism. 61
31792158 2019
115
Orthotic Care Based on the Ferrari Concept for Children and Adults with Meningomyelocele. 61
31291672 2019
116
Fractional Limb Volume in Spina Bifida Fetuses as an Assessment Tool for Postnatal Ambulation. 61
31805563 2019
117
Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. 61
30864008 2019
118
Towards Guideline-Based Management of Tethered Cord Syndrome in Spina Bifida: A Global Health Paradigm Shift in the Era of Prenatal Surgery. 61
31284336 2019
119
Pleth Variable Index in infants undergoing myelomeningocele repair. 61
31112868 2019
120
Chorioamniotic membrane separation following fetal myelomeningocele repair: incidence, risks factors and impact on perinatal outcome. 61
31841246 2019
121
Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty. 61
31653462 2019
122
Immediate effect of transcutaneous electrical nerve stimulation on urodynamic parameters of children with myelomeningocele. 61
31486143 2019
123
In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion. 61
31407874 2019
124
Trends in ventricle size during pregnancy and its use for prediction of ventriculoperitoneal shunt in fetal myelomeningocele. 61
31763720 2019
125
Comparison of two fetoscopic open neural tube defect (ONTD) repair techniques: Single-layer vs three-layer closure. 61
31709658 2019
126
Morphometric Features of the Latissimus Dorsi Muscle in Fetal Cadavers With Meningomyelocele for Prenatal Surgery. 61
31369512 2019
127
Growth disorders in children and adolescents affected by syndromes or diseases associated with neurodysfunction. 61
31712660 2019
128
Psychosocial outcomes for adults with spina bifida: a scoping review protocol. 61
31714450 2019
129
A case report of triple neural tube defect: revisiting the multisite closure theory. 61
31694612 2019
130
The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study. 61
31465293 2019
131
Concepts in the neurosurgical care of patients with spinal neural tube defects: An embryologic approach. 61
31576681 2019
132
Predictors of surgical treatment in children with tethered fibrofatty filum terminale. 61
31675690 2019
133
Are primary and secondary types of brain anomalies exclusive factors affecting the attention networks in individuals with spina bifida? 61
31282688 2019
134
Early Vs. Expectant Management of Spina Bifida Patients-Are We All Talking About a Risk Stratified Approach? 61
31734847 2019
135
Increased complications without neurological benefit are associated with prophylactic spinal cord untethering prior to scoliosis surgery in children with myelomeningocele. 61
31267182 2019
136
Intracranial infection in patients with myelomeningocele: profile and risk factors. 61
31289854 2019
137
Myelomeningocele: Medical Considerations and Stomatologic Aspects in the Dental Treatment. 61
31567772 2019
138
Letter to the Editor. Fetal closure of myelomeningocele. 61
31783359 2019
139
Sleep-disordered breathing: an under-recognized problem in infants with myelomeningocele defects regardless of timing of repair. 61
31320719 2019
140
Cost of prenatal versus postnatal myelomeningocele closure for both mother and child at 1 year of life. 61
31574469 2019
141
Correction to: Sleep-disordered breathing: an under-recognized problem in infants with myelomeningocele defects regardless of timing of repair. 61
31471577 2019
142
A comparison of the accuracy of fetal MRI and prenatal ultrasonography at predicting lesion level and perinatal motor outcome in patients with myelomeningocele. 61
31574478 2019
143
In Utero Treatment of Myelomeningocele with Placental Mesenchymal Stromal Cells - Selection of an Optimal Cell Line in Preparation for Clinical Trials. 61
31672407 2019
144
Maternal and obstetric complications in fetal surgery for prenatal myelomeningocele repair: a systematic review. 61
31574465 2019
145
Progressive hydrocephalus despite early complete reversal of hindbrain herniation after prenatal open myelomeningocele repair. 61
31574467 2019
146
Thirty-day medical and surgical readmission following prenatal versus postnatal myelomeningocele repair. 61
31574468 2019
147
Using the keystone design perforator island flap in large myelomeningocele closure. 61
31574473 2019
148
Pediatric neurosurgeons' views regarding prenatal surgery for myelomeningocele and the management of hydrocephalus: a national survey. 61
31574481 2019
149
Editorial. Shifting paradigms: how pediatric neurosurgeons view prenatal closure for myelomeningocele. 61
31574482 2019
150
Bladder Function after Prenatal Closure of Myelomeningocele: A Word of Caution. 61
31766094 2019
151
Intravesical Electromotive Botulinum Toxin Type A (Dysport) Administration in Children With Myelomeningocele. 61
31299327 2019
152
A Comparison of Dressing Techniques for Presurgical Closure of Myelomeningocele in the Neonate. 61
31469703 2019
153
Commentary: Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele: Executive Summary. 61
31504773 2019
154
Meningomyelocele with unusual feet deformity combination: A report of a rare case. 61
31728147 2019
155
The role of sacral laminoplasty in the management of spina bifida and sacral cystic lesions: case series. 61
31574475 2019
156
Postural Stability in Children with High Sacral Level Spina Bifida: Deviations from a Control Group. 61
31630669 2019
157
Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review. 61
31574479 2019
158
SOX3 duplication: A genetic cause to investigate in fetuses with neural tube defects. 61
31299102 2019
159
Sleep in infants with myelomeningocele-an opportunity to improve outcomes? 61
31420583 2019
160
Human Milk and Breastfeeding Outcomes in Infants With Myelomeningocele. 61
31651472 2019
161
Impact of body mass index on 30-day postoperative morbidity in pediatric and adolescent patients undergoing continent urinary tract reconstruction. 61
31301974 2019
162
Neurobehavioral outcomes in patients with myelomeningocele. 61
31574480 2019
163
Neurosurgeons' opinions on the prenatal management of myelomeningocele. 61
31574464 2019
164
Contemporary management and outcome of myelomeningocele: the Rotterdam experience. 61
31574477 2019
165
Effect of Prenatal Repair of Myelomeningocele on Urological Outcomes at School Age. 61
31075056 2019
166
Minimally invasive fetal surgery for myelomeningocele: preliminary report from a single center. 61
31574466 2019
167
Reviewing the prognostic factors in myelomeningocele. 61
31574474 2019
168
Kyphectomy in Myelomeningocele for Severe Early-Onset Kyphosis Using Distal Intravertebral Fixation and Thoracic Growing Rods. 61
31773078 2019
169
Acellular Dermal Matrix as a Definitive Reconstructive Option for Management of a Large Myelomeningocele Defect in the Setting of Severe Lumbar Kyphosis. 61
31247357 2019
170
Fecal Incontinence and Neurogenic Bowel Dysfunction in Women With Traumatic and Nontraumatic Spinal Cord Injury. 61
31318774 2019
171
Interhypothalamic adhesions in endoscopic third ventriculostomy. 61
31172270 2019
172
Experience with various reconstructive techniques for meningomyelocele defect closure in India. 61
32158889 2019
173
Antenatal ultrasound compared to MRI evaluation of fetal myelomeningocele: a prenatal and postnatal evaluation. 61
31487264 2019
174
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Management of Patients With Myelomeningocele: Whether Persistent Ventriculomegaly Adversely Impacts Neurocognitive Development. 61
31418036 2019
175
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Closure of Myelomeningocele Within 48 Hours to Decrease Infection Risk. 61
31418041 2019
176
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele: Executive Summary. 61
31418038 2019
177
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Incidence of Tethered Cord Syndrome in Infants With Myelomeningocele With Prenatal Versus Postnatal Repair. 61
31418037 2019
178
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Incidence of Shunt-Dependent Hydrocephalus in Infants With Myelomeningocele After Prenatal Versus Postnatal Repair. 61
31418039 2019
179
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on the Management of Patients With Myelomeningocele: Whether Prenatal or Postnatal Closure Affects Future Ambulatory Status. 61
31418040 2019
180
Myelomeningocele with Associated Anomalies – Case Report and Literature Review. 61
32337935 2019
181
The role of appetite-regulating hormones: Ghrelin and leptin in the nutritional status of children with neurogenic bladder due to myelomeningocele. 61
30488610 2019
182
Kyphectomy and interbody fixation using lag screws in a child with myelomeningocele kyphosis: a technical case report. 61
31139905 2019
183
Biomaterials in fetal surgery. 61
31099350 2019
184
South African adolescents living with spina bifida: contributors and hindrances to well-being. 61
31368378 2019
185
Neurogenic Bladder Dysfunction as Signal of Late Failure of Endoscopic Third Ventriculostomy in Child with Spina Bifida. 61
31132484 2019
186
Care management and contemporary challenges in spina bifida: a practice preference survey of the American Society of Pediatric Neurosurgeons. 61
31470398 2019
187
A case-control analysis of maternal diet and risk of neural tube defects in Bangladesh. 61
30989821 2019
188
Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. 61
31329379 2019
189
Timing of Shunt Insertion in Children with Neural Tube Defects and Hydrocephalus: A Clinical Study. 61
31608965 2019
190
YouTube as a Source of Patient Information for Prenatal Repair of Myelomeningocele. 61
31430813 2019
191
Fetal surgery for spina bifida. 61
31370010 2019
192
Fetal myelomeningocele repair. 61
31451171 2019
193
Factors Associated with Timeliness of Surgical Repair among Infants with Myelomeningocele: California Perinatal Quality Care Collaborative, 2006 to 2011. 61
31307103 2019
194
Long-term follow-up of myelomeningocele defect closure with dorsal intercostal artery perforator propeller flaps. 61
30610481 2019
195
Nationwide survey of fetal myelomeningocele in Japan: Background for fetal surgery. 61
31116463 2019
196
Enhancing nodular lesions in Chiari II malformations in the setting of persistent hindbrain herniation: case report and literature review. 61
31062141 2019
197
Endoscopic Third Ventriculostomy in Cases of Ventriculoperitoneal Shunt Malfunction: Does Shunt Duration Play a Role? 61
30954740 2019
198
Meningomyelocele on Exposure to Clozapine During Perinatal Period. 61
31391678 2019
199
Evaluation of Neural Tube Defects (NTDs) After Exposure to Raltegravir During Pregnancy. 61
30908331 2019
200
Real prevalence of neural tube defects in Japan: How many of such pregnancies have been terminated? 61
30883906 2019
201
Open fetal surgery for neural tube defects. 61
31078425 2019
202
Prevalence of Congenital Anomalies in the Japan Environment and Children's Study. 61
30249945 2019
203
Morbidity and cost burden of prenatal myelomeningocele repair. 61
31345076 2019
204
Bladder Self-management in the Transition to Adulthood With Spina Bifida in 3 Countries: A Comparative Study. 61
31274863 2019
205
Program Evaluation of Camp V.I.P: Promoting Self-confidence and Independence for Patients with Spina Bifida. 61
31026678 2019
206
Economic benefit of neurosurgical intervention for infant hydrocephalus in Haiti. 61
31277055 2019
207
Proceedings of the First Annual Meeting of the International Fetoscopic Myelomeningocele Repair Consortium. 61
31169957 2019
208
Altered Amniotic Fluid Levels of Hyaluronic Acid in Fetal Rats with Myelomeningocele: Understanding Spinal Cord Injury. 61
30284959 2019
209
Quadruple Perforator Flaps for Primary Closure of Large Myelomeningoceles: An Evaluation of the Butterfly Flap Technique. 61
31085942 2019
210
Low level myelomeningoceles: do they need prenatal surgery? 61
30915531 2019
211
Lumbar Intramedullary Epidermoid Following Repair of Sacral Myelomeningocele and Tethered Cord: A Case Report With a Review of the Relevant Literature and Operative Nuances. 61
30653913 2019
212
Intrauterine closure of myelomeningocele is associated with superior long-term quality of life than postnatal closure: a single-center study. 61
31100721 2019
213
Primary External Ventricular Drains in the Management of Open Myelomeningocele Repairs in the Neonatal Setting in Ireland 61
31411012 2019
214
Anal Extrusion of a Ventriculoperitoneal Shunt. 61
31036124 2019
215
Delayed-Interval Delivery of Twin Gestation via Cesarean Section: A Case Report. 61
31127078 2019
216
Microvascular Fluorescence in Spinal Cord Repair. 61
30735880 2019
217
Arthrogryposis in a Case of Chiari Malformation II: First Case Report in a Mediterranean Population. 61
31105263 2019
218
Subsequent pregnancy outcomes after open maternal-fetal surgery for myelomeningocele. 61
30885769 2019
219
Predictors of success for combined endoscopic third ventriculostomy and choroid plexus cauterization in a North American setting: a Hydrocephalus Clinical Research Network study. 61
31151098 2019
220
The Spinal Structure and Lung Function Relationship in an Untreated Nonambulatory Myelomeningocele Group of Patients. 61
30252790 2019
221
Clinical outcome of V-Y flap with latissimus dorsi and gluteal advancement for treatment of large thoracolumbar myelomeningocele defects: a comparative study. 61
31003224 2019
222
Kyphectomy in neonates with meningomyelocele. 61
30539295 2019
223
Comparing the Ease of Mask Ventilation, Laryngoscopy, and Intubation in Supine and Lateral Position in Infants with Meningomyelocele. 61
31198231 2019
224
Health behaviors and disordered eating in adolescents and young adults with spina bifida: results from a national survey. 61
30978107 2019
225
Ethical and Legal Dilemmas Around Termination of Pregnancy for Severe Fetal Hydrocephalus, Spina Bifida Aperta and Meningomyelocoella. 61
31391703 2019
226
Dizygotic opposite-sex twins with surgically repaired concordant myelomeningocele conceived by in vitro fertilization using intracytoplasmic sperm injection: a case report and review of the literature. 61
30349985 2019
227
Neural Tube Defects: A Retrospective Study of 69 Cases. 61
31143270 2019
228
Bladder function and fetal treatment of myelomeningocele. 61
30854800 2019
229
Predictors of endoscopic third ventriculostomy ostomy status in patients who experience failure of endoscopic third ventriculostomy with choroid plexus cauterization. 61
31003223 2019
230
Endoscopic Third Ventriculostomy in Children with Failed Ventriculoperitoneal Shunt. 61
31143252 2019
231
[Misdirection of a Catheter for Clean Intermittent Catheterization into the Upper Ureter in a Female Patient with Neurogenic Bladder Due to Myelomeningocele : A Case Report]. 61
31247690 2019
232
Team Approach: Guideline-Based Management of Skin Injury in Individuals with Myelomeningocele. 61
30844844 2019
233
Heated humidified carbon dioxide for partial uterine insufflation in fetoscopic myelomeningocele repair: insights from animal model. 61
30835369 2019
234
Doppler changes in umbilical artery and ductus venosus during fetoscopic prenatal surgical repair of myelomeningocele. 61
30426574 2019
235
An Injectable Reverse Thermal Gel for Minimally Invasive Coverage of Mouse Myelomeningocele. 61
30691800 2019
236
Congenital Bathing Trunk Nevus with Meningomyelocele. 61
30984601 2019
237
Classic metaphyseal lesion acquired during physical therapy. 61
30611094 2019
238
Prenatal brain imaging for predicting need for postnatal hydrocephalus treatment in fetuses that had neural tube defect repair in utero. 61
30620440 2019
239
Short-term results of patients with neural tube defects followed-up in the Konya region, Turkey. 61
30708397 2019
240
Maternal anaesthesia in open and fetoscopic surgery of foetal open spinal neural tube defects: A retrospective cohort study. 61
30507621 2019
241
Osteomyelitis Secondary to Ponseti Method for the Treatment of Clubfoot Associated with Meningomyelocele. 61
31183281 2019
242
Complex spinal dysraphism: myelomenigocele associated with dorsal bony spur, split cord malformation type I, syringomyelia, lipoma and tethered cord. 61
30836021 2019
243
Role of Neurocognitive Factors in Academic Fluency for Children and Adults With Spina Bifida Myelomeningocele. 61
30864535 2019
244
Does fetoscopic or open repair for spina bifida affect fetal and postnatal growth? 61
30672627 2019
245
Hip Status and Long-term Functional Outcomes in Spina Bifida. 61
30300276 2019
246
Amniotic membrane and placental histopathological findings after open and fetoscopic prenatal neural tube defect repair. 61
30609053 2019
247
Reconstructions With Different and New Techniques of Large and Extensive Myelomeningocele Defects. 61
30394972 2019
248
An Unreported Complication After Fetoscopic Myelomeningocele Closure. 61
30676450 2019
249
Intraspinal Inclusion Tumor After Myelomeningocele Repair: A Long-Term Single-Center Experience. 61
30448586 2019
250
Use of plastic wound retractor at hysterotomy site in prenatal repair of myelomeningocele: a new technique. 61
30616410 2019
251
Urinary continence appears to enhance social participation and intimate relations in adolescents with myelomeningocele. 61
30228091 2019
252
Using poly(l-lactic acid) and poly(ɛ-caprolactone) blends to fabricate self-expanding, watertight and biodegradable surgical patches for potential fetoscopic myelomeningocele repair. 61
29770571 2019
253
Long-term results using a transanal irrigation system (Peristeen®) for treatment of stool incontinence in children with myelomeningocele. 61
30245057 2019
254
Spinal Cord Stimulation in Adult Tethered Cord Syndrome: Case Report and Review of the Literature. 61
30415046 2019
255
Bowel management program in patients with spina bifida. 61
30402681 2019
256
Expression profiles of pro-inflammatory and pro-apoptotic mediators in secondary tethered cord syndrome after myelomeningocele repair surgery. 61
30280214 2019
257
The Impact of Prenatal Diagnosis of Selected Central Nervous System Anomalies for Prenatal Counselling Based on Significant Pregnancy Morbidity and Neonatal Outcomes. 61
30316708 2019
258
Peri-operative considerations for in utero repair of myelomeningocele. 61
30514591 2019
259
High density placental mesenchymal stromal cells provide neuronal preservation and improve motor function following in utero treatment of ovine myelomeningocele. 61
30529115 2019
260
MOMS Plus: Single-Institution Review of Outcomes for Extended BMI Criteria for Open Fetal Repair of Myelomeningocele. 61
31048584 2019
261
Urinary and Fecal Continence in 5-Year-Old Patients Who Underwent in utero Myelomeningocele Repair: A Prospective Study. 61
30884481 2019
262
Alginate microparticles loaded with basic fibroblast growth factor induce tissue coverage in a rat model of myelomeningocele. 61
30414695 2019
263
Multisegmental Lumbar Corporectomy and Transcorporal Fixation for Correction of Extreme Thoracolumbar Kyphosis in Myelomeningocele with Chronic Decubitus. 61
30481786 2019
264
Comparison of Dorsal Intercostal Artery Perforator Propeller Flaps and Bilateral Rotation Flaps in Reconstruction of Myelomeningocele Defects. 61
29694666 2019
265
Spinal Angulation: A Limitation of the Fetal Lamb Model of Myelomeningocele. 61
30970373 2019
266
Indomethacin Dosing and Constriction of the Ductus Arteriosus During Open Fetal Surgery for Myelomeningocele Repair. 61
30157479 2019
267
Implications of Bacteriuria in Myelomeningocele Patients at Time of Urodynamic Testing. 61
31548791 2019
268
Commentary on "Early Treadmill Practice in Infants Born With Myelomeningocele: A Pilot Study". 61
30557285 2019
269
Early Treadmill Practice in Infants Born With Myelomeningocele: A Pilot Study. 61
30507852 2019
270
[(3)Treatment for Hydrocephalus with Myelomeningocele in Infant:CSF Shunt vs. ETV]. 61
30696789 2019
271
Re: Perinatal outcomes after open fetal surgery for myelomeningocele repair: a retrospective cohort study. 61
30320494 2019
272
Re: Perinatal outcomes after open fetal surgery for myelomeningocele repair: a retrospective cohort study. 61
30320496 2019
273
Myelomeningocele: need for long-time complex follow-up-an observational study. 61
30891504 2019
274
Review on myelomeningocele management and its current status in Saudi Arabia. 61
30842393 2019
275
A clinician's concerns about motor function outcomes of fetal surgery for myelomeningocele. 61
30243606 2019
276
Damaged cardiovascular autonomic control in wheelchair-using children and adolescents with myelomeningocele: a case-control study. 61
30243858 2019
277
Distal Ventriculoatrial Shunt Revision in Adult Myelomeningocele Patient Performed via Endovascular Transvenous Approach. 61
30266696 2019
278
RE: Pastuszka et al. Prenatal myelomeningocele repair improves urinary continence and reduces the risk of constipation. 61
30411814 2019
279
Early Administration of Magnesium Sulfate during Open Fetal Myelomeningocele Repair Reduces the Dose of Inhalational Anesthesia. 61
29672287 2019
280
Untreated meningomyelocele and squamous cell carcinoma: a case report and literature review. 61
30652927 2019
281
Reconstruction of Lumbar Spinal Defects: Case Series, Literature Review, and Treatment Algorithm. 61
30859046 2019
282
Scalp Intravenous Catheter Infiltration Leading to Subdural and Intraparenchymal Fluid Collection and Severe Neurologic Sequelae: A Case Report. 61
30939275 2019
283
In vitro artificial skin engineering by decellularized placental scaffold for secondary skin problems of meningomyelocele. 61
30385168 2019
284
The perinatal revolution. 61
31179670 2019
285
Spontaneously resolved uterine prolapse in a neonate with spina bifida. 61
32134599 2019
286
Experience in the Early Surgical Management of Myelomeningocele in Zanzibar. 61
30268549 2019
287
Fetal myelomeningocele diagnosed in the antenatal period: Maternal-fetal characteristics and their relationship with pregnancy decision-making. 61
31381533 2019
288
[Prenatal myelomeningocele repair - a chance to improve the quality of life]. 61
31398173 2019
289
Urological Surveillance and Medical Complications in the United States Adult Spina Bifida Population. 61
28935364 2019
290
Environmental buttocks burns in children and adolescents with spina bifida in the Southwestern United States. 61
31744035 2019
291
An Exploratory Electrical Stimulation Protocol in the Management of an Infant With Spina Bifida: A Case Report. 61
31259192 2019
292
Language and Latino immigrants living with spina bifida: Social determinants of health - the missing dimension in quality of life research. 61
31744031 2019
293
Clinical and Histologic Evaluation of the Hysterotomy Site and Fetal Membranes after Open Fetal Surgery for Fetal Spina Bifida Repair. 61
30048967 2019
294
Two-Port Fetoscopic Repair of Myelomeningocele in Fetal Lambs. 61
29466789 2019
295
Fetal myelomeningocele surgery: Only treating the tip of the iceberg. 61
30536580 2019
296
Cerebral Diffusivity Changes in Fetuses with Chiari II Malformation. 61
30121678 2019
297
Evaluation of Lower Extremities' Vascular Characteristics in Myelomeningocele Patients: A Case-Control Study. 61
31487737 2019
298
Can dynamic ultrasonography replace urodynamics in the follow-up of patients with myelomeningocele? A prospective concurrent study. 61
30350876 2019
299
Effectiveness of Prenatal Intervention on the Outcome of Diseases That Have a Postnatal Urological Impact. 61
31001504 2019
300
Preoperative Variables Associated With Respiratory Complications After Pediatric Neuromuscular Spine Deformity Surgery. 61
30587301 2019
301
Preoperative Variables Associated With Respiratory Complications After Pediatric Neuromuscular Spine Deformity Surgery. 61
31975254 2019
302
Risk Factors for Wound Infections after Deformity Correction Surgery in Neuromuscular Scoliosis. 61
30783030 2019
303
Decreased respiratory performance of children and adolescents with myelomeningocele who use a wheelchair - preliminary data. 61
31389492 2019
304
Maternal Complications following Open Fetal Myelomeningocele Repair at the Zurich Center for Fetal Diagnosis and Therapy. 61
30428477 2019
305
The Use of Indomethacin with Complete Amniotic Fluid Replacement and Classic Hysterotomy for the Reduction of Perinatal Complications of Intrauterine Myelomeningocele Repair. 61
31085918 2019
306
Dynamic magnetic resonance imaging parameters for objective assessment of the magnitude of tethered cord syndrome in patients with spinal dysraphism. 61
30456429 2019
307
Local Flaps with Negative Pressure Wound Therapy in Secondary Reconstruction of Myelomeningocele Wound Necrosis. 61
30656109 2018
308
Myelomeningocele Versus Myelocele on Fetal MR Images: Are There Differences in Brain Findings? 61
30332293 2018
309
A study to assess global availability of fetal surgery for myelomeningocele. 61
30378145 2018
310
Saphenous nerve transfer: A new approach to restore sensation of the sole. 61
30174287 2018
311
Human Amniotic Fluid Stem Cells: Therapeutic Potential for Perinatal Patients with Intractable Neurological Disease. 61
29515049 2018
312
Simultaneous Robotic-Assisted Laparoscopy for Bladder and Bowel Reconstruction. 61
29924670 2018
313
Partial amniotic carbon dioxide insufflation for fetal surgery. 61
30238473 2018
314
Decompression for Chiari malformation type II in individuals with myelomeningocele in the National Spina Bifida Patient Registry. 61
30141752 2018
315
Co-morbidities Associated With Early Mortality in Adults With Spina Bifida. 61
29757766 2018
316
Lost in transition: Patient-identified barriers to adult urological spina bifida care. 61
30061086 2018
317
Treated hydrocephalus in individuals with myelomeningocele in the National Spina Bifida Patient Registry. 61
30141753 2018
318
Fetal Surgery and Delayed Cord Clamping: Neonatal Implications. 61
30447809 2018
319
Treatment of non-idiopathic clubfeet with the Ponseti method: a systematic review. 61
30607204 2018
320
The effect of spinal bracing on sitting function in children with neuromuscular scoliosis. 61
29871529 2018
321
Prenatal myelomeningocele repair improves urinary continence and reduces the risk of constipation. 61
30058735 2018
322
The Prevalence of Scoliosis in Spina Bifida Subpopulations: A Systematic Review. 61
29757767 2018
323
Myelocystocele Mimicking Myelomeningocele: A Case Report and Review of the Literature. 61
30092480 2018
324
Ethical Issues in Intrauterine Myelomeningocele Surgery. 61
30235082 2018
325
Respiratory morbidities in late preterm and term infants with myelomeningocele. 61
30166620 2018
326
Myelomeningocele closure by unilateral lumbar artery perforator flap: Experience with thirty-eight patients. 61
29953654 2018
327
Fetal modified left myocardial performance index monitoring during open surgery for myelomeningocele repair. 61
29943857 2018
328
Prenatal Sonographic Head Circumference and Cerebral Ventricle Width Measurements Before and After Open Fetal Myelomeningocele Repair - Prediction of Shunting During the First Year of Life. 61
30347419 2018
329
Anterior distal femoral hemiepiphysiodesis can reduce fixed flexion deformity of the knee: a retrospective study of 83 knees. 61
29902104 2018
330
Comparison Of Simultaneous Versus Delayed Ventriculoperitoneal Shunting In Patients Undergoing Meningocoele Repair In Terms Of Infection. 61
30632328 2018
331
Pediatric neurosurgical bellwether procedures for infrastructure capacity building in hospitals and healthcare systems worldwide. 61
30030605 2018
332
Ileal Continent Reservoir: A Feasible Option for Bladder Augmentation and Urinary Diversion. 61
29958971 2018
333
V-Y Plasty or Primary Repair Closure of Myelomeningocele: Our Experience. 61
30937079 2018
334
Fetoscopic two-layer closure of open neural tube defects. 61
29876992 2018
335
Neural tube defects in Uganda: follow-up outcomes from a national referral hospital. 61
30269577 2018
336
Percutaneous fetoscopic closure of large open spina bifida using a bilaminar skin substitute. 61
29314321 2018
337
Subspecialty pediatric neurosurgery training: a skill-based training model for neurosurgeons in low-resourced health systems. 61
30269595 2018
338
Effect of Custom-Made Foot Orthosis for Scoliosis with Pelvic Malalignment in a Patient with Myelomeningocele of Partial Neurological Deficit: A Case Report. 61
30315149 2018
339
Clinical evaluation and surveillance imaging of children with myelomeningocele and shunted hydrocephalus: a follow-up study. 61
30497223 2018
340
Using subdural strip electrodes to define functional sensory nerves and the most inferior functional portion of the conus medullaris during detethering surgeries for tethered cord syndrome: a pilot study. 61
30004314 2018
341
Twenty years' experience with myelomeningocele management at a single institution: lessons learned. 61
30004312 2018
342
Scintigraphic evaluation of colonic transit in children with constipation using 67Ga-citrate. 61
30505222 2018
343
Fetal blood-gas values during fetoscopic myelomeningocele repair performed under carbon dioxide insufflation. 61
29750436 2018
344
Children with myelomeningocele do not exhibit normal remodeling of tibia roundness with physical development. 61
29991457 2018
345
Perinatal outcomes after open fetal surgery for myelomeningocele repair: a retrospective cohort study. 61
29878531 2018
346
Repair of myelomeningocele using autologous amnion graft and local flaps. A report of two cases. 61
32158825 2018
347
Surgeries and Health Outcomes Among Patients With Spina Bifida. 61
30158199 2018
348
Fetal blood gases at fetoscopic myelomeningocele repair. 61
30022559 2018
349
Myelomeningocele in slovenia: results of a 10 years follow-up. 61
30259717 2018
350
Our experience with ureterocystoplasty in bilateral functional kidneys. 61
30201076 2018
351
Clinical outcomes of non-surgical management of detrusor leak point pressures above 40 cm water in adults with congenital neurogenic bladder. 61
29488655 2018
352
Reversible ventriculoperitoneal shunt dysfunction and chronic constipation: case report. 61
29749881 2018
353
Generation of integration-free induced pluripotent stem cells from a patient with spina bifida. 61
30007220 2018
354
Improved Bowel Function in Patients with Spina Bifida After Bone Marrow-Derived Mononuclear Cell Transplantation: A Report of 2 Cases. 61
30143601 2018
355
Homologous cryopreserved amniotic membrane in the repair of myelomeningocele: preliminary experience. 61
29858946 2018
356
Considerations for Testing and Treating Children with Central Vestibular Impairments. 61
30038458 2018
357
Intelligence Quotient in Patients with Myelomeningocele: A Review. 61
30345194 2018
358
Perioperative complications and risk factors in neuromuscular scoliosis surgery. 61
29749884 2018
359
Experience in shunt management on revision free survival in infants with myelomeningocele. 61
29582171 2018
360
Isolated Post-Shunt Metopic Synostosis and Neural Tube Defects. 61
29561489 2018
361
Adipofascial Flaps With Acellular Dermal Matrix Compared With Myocutaneous Flap Reconstruction in Lumbar Myelomeningocele Defects. 61
29750727 2018
362
Bladder Management and Continence Outcomes in Adults with Spina Bifida: Results from the National Spina Bifida Patient Registry, 2009 to 2015. 61
29588216 2018
363
Complications, Results, and Risk Factors of Spinal Fusion in Patients With Myelomeningocele. 61
29886920 2018
364
Complications, Results, and Risk Factors of Spinal Fusion in Patients With Myelomeningocele. 61
31981190 2018
365
Surgical treatment of patients with myelomeningocele-related spine deformities: study of 26 cases. 61
29372371 2018
366
Prenatal superior to postnatal myelomeningocele surgery. 61
29936963 2018
367
Spontaneous Pneumocephalus Secondary to Leaking Myelomeningocele. 61
30271466 2018
368
Ultrasound-based three-dimensional printed medical model for multispecialty team surgical rehearsal prior to fetoscopic myelomeningocele repair. 61
28850758 2018
369
Percutaneous nephrolithotomy in an 8-week-old infant. 61
29900827 2018
370
Development of severe hyponatremia due to cerebrospinal fluid leakage following meningomyelocele surgery in a newborn. 61
29521607 2018
371
Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study. 61
29522865 2018
372
Management of Labor and Delivery After Fetoscopic Repair of an Open Neural Tube Defect. 61
29742660 2018
373
Tailored Strategies to Manage Cerebrospinal Fluid Leaks or Pseudomeningocele After Surgery for Tethered Cord Syndrome. 61
29605699 2018
374
Coincident myelomeningocele and gastroschisis: report of 2 cases. 61
29521606 2018
375
Predictors of mortality in children with myelomeningocele and symptomatic Chiari type II malformation. 61
29570035 2018
376
Shunt revision rates in myelomeningocele patients in the first year of life: a retrospective study of 52 patients. 61
29159427 2018
377
The Use of a Wheelchair Propulsion Field Test to Determine Peak Heart Rate in Children and Adolescents With Myelomeningocele. 61
29485935 2018
378
Duplex Ultrasonography-Assisted Freestyle Pedicled Perforator Flaps for the Repair of Myelomeningocele Defects. 61
29319575 2018
379
A case of prenatally diagnosed limited dorsal myeloschisis with good prognosis. 61
28980329 2018
380
Uropathogens and Pyuria in Children With Neurogenic Bladders. 61
29618582 2018
381
Latex sensitization in patients with myelomeningocele: contribution of microarray technique. 61
29479928 2018
382
Medical and socioeconomic predictors of quality of life in myelomeningocele patients with shunted hydrocephalus. 61
29249073 2018
383
Trends in incidence and long-term outcomes of myelomeningocele in British Columbia. 61
29236131 2018
384
Long-term follow-up for keystone design perforator island flap for closure of myelomeningocele. 61
29255922 2018
385
[Neonate with Ventriculitis caused by Empedobacter Brevis: Report of a case in Peru]. 61
30183909 2018
386
How much do plastic surgeons add to the closure of myelomeningoceles? 61
29222684 2018
387
Neurosurgical management of hydrocephalus by a general surgeon in an extremely low resource setting: initial experience in North Kivu province of Eastern Democratic Republic of Congo. 61
29453580 2018
388
Intravesical Electromotive Botulinum Toxin Type "A" Administration for Management of Urinary Incontinence Secondary to Neuropathic Detrusor Overactivity in Children: Long-term Follow-up. 61
29229221 2018
389
Functional Mobility Improved After Intensive Progressive Resistance Exercise in an Adolescent With Spina Bifida. 61
29579008 2018
390
Transpsoas cystolitholapaxy in a pediatric patient with myelomeningocele, augmented neobladder, and Mitrofanoff appendicovesicostomy. 61
29904501 2018
391
Congenital lumbar kyphosis with skin ulceration and osteomyelitis in a myelomeningocele child: a case report. 61
28918465 2018
392
Updates in fetal spina bifida repair. 61
29489502 2018
393
Comparison of hydrocephalus metrics between infants successfully treated with endoscopic third ventriculostomy with choroid plexus cauterization and those treated with a ventriculoperitoneal shunt: a multicenter matched-cohort analysis. 61
29393809 2018
394
Adult Versus Pediatric Tethered Cord Syndrome: Clinicoradiological Differences and its Management. 61
29682019 2018
395
Surgical Management of Myelomeningocele-Related Spinal Deformities. 61
29355795 2018
396
Cerebellar herniation demonstrated by the occipitum-dens line: Ultrasonography assessment of normal fetuses, fetuses with myelomeningocele, and fetuses that underwent antenatal myelomeningocele surgery. 61
29427561 2018
397
Strategies and dental care in the treatment of patients with myelomeningocele. 61
29512828 2018
398
A Descriptive, Retrospective Study of Using an Oblique Downward-design Gluteus Maximus Myocutaneous Flap for Reconstruction of Ischial Pressure Ulcers. 61
29584611 2018
399
Incidental Discovery of Adenocarcinoma of an Augmented Bladder in a Patient With Myelomenigocele Undergoing Cystolithotomy. 61
29196068 2018
400
Role of ultrasound guided epidural anesthesia for lower limb surgery in children with previously repaired meningomyelocele. 61
29285839 2018
401
Spinal Arteriovenous Vascular Malformations in Patients with Neural Tube Defects. 61
29284599 2018
402
Longitudinal Study of Bladder Continence in Patients with Spina Bifida in the National Spina Bifida Patient Registry. 61
29132982 2018
403
Central Sleep Apnea - a Rare Cause for Acute Respiratory Insufficiency in Children. Case Report. 61
29868143 2018
404
Sleep-Disordered Breathing among Newborns with Myelomeningocele. 61
29221695 2018
405
Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus: a prospective study by the Hydrocephalus Clinical Research Network. 61
29243972 2018
406
Body composition and energy expenditure in a population of children and adolescents with myelomeningocele. 61
29333813 2018
407
The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. 61
29246577 2018
408
Meningomyelocele Simulation Model: Pre-surgical Management-Technical Report. 61
29713576 2018
409
Nasogastric tube as abdominal pressure sensor in urodynamics-Proof of concept of a novel approach. 61
28724187 2018
410
The pattern, peculiarities, and management challenges of spina bifida in a teaching hospital in Southwest Nigeria. 61
29026989 2018
411
A mendelian form of neural tube defect caused by a de novo null variant in SMARCC1 in an identical twin. 61
29360170 2018
412
Nervous System Malformations. 61
29432238 2018
413
Postnatal Management of Myelomeningocele: Outcome with a Multidisciplinary Team Experience. 61
28987842 2018
414
Amniotic Fluid Concentrations of Glial Fibrillary Acidic Protein Do Not Correlate with Prenatal Metrics in Fetuses with Myelomeningocele. 61
28768252 2018
415
Independence in self-care activities in children with myelomeningocele: exploring factors based on the International Classification of Function model. 61
27830629 2018
416
Fetal Surgery for Myelomeningocele: A Systematic Review and Meta-Analysis of Outcomes in Fetoscopic versus Open Repair. 61
28910784 2018
417
Does Shunt Selection Affect the Rate of Early Shunt Complications in Neonatal Myelomeningocele-Associated Hydrocephalus? A Multi-Center Study. 61
27593850 2018
418
The experience of parents with children with myelomeningocele who underwent prenatal surgery. 61
30507587 2018
419
Energy Efficiency in Children With Myelomeningocele During Acute Use of Assistive Devices: A Pilot Study. 61
29313712 2018
420
The Use of External Ventricular Drainage to Reduce the Frequency of Wound Complications in Myelomeningocele Closure. 61
29316543 2018
421
Pain and health status in adults with myelomeningocele living in Sweden. 61
30507588 2018
422
Hemodynamic monitoring for fetal surgery: open versus fetoscopic repair of myelomeningocele. 61
30615799 2018
423
Morphometric properties of the tensor fascia lata muscle in human foetuses. 61
29345722 2018
424
Unusual Clinical Presentation and Association of Cranial Dermoid Tumor and Tethered Cord Syndrome. 61
30408795 2018
425
Low-Fidelity Simulator for the Standardized Training of Fetoscopic Meningomyelocele Repair. 61
29215525 2018
426
Modified Hysterotomy Closure Technique for Open Fetal Surgery. 61
28873371 2018
427
Relationship between hydrocephalus etiology and ventriculoperitoneal shunt infection in children and review of literature. 61
29371715 2018
428
Comparing neurodevelopmental outcomes at 30 months by presence of hydrocephalus and shunt status among children enrolled in the MOMS trial. 61
30507586 2018
429
First Clinical Applications of a High-Definition Three-Dimensional Exoscope in Pediatric Neurosurgery. 61
29581920 2018
430
Incidence and Management of Umbilical Artery Flow Abnormalities during Open Fetal Surgery. 61
28848121 2018
431
Iniencephaly. 61
29377645 2018
432
Pure Tethered Cervical Cord and Review of Literature. 61
29492126 2018
433
Endoscopic Management of Arnold-Chiari Malformation Type I with or without Syringomyelia. 61
28586935 2018
434
Intellectual efficiency in children and adolescents with spina bifida myelomeningocele and shunted hydrocephalus. 61
29451990 2018
435
Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry. 61
28830753 2018
436
Factors Influencing the Use of Intermittent Bladder Catheterization by Individuals With Spina Bifida in Brazil and Germany. 61
27775158 2018
437
Ultrasound in Prenatal Diagnostics and Its Impact on the Epidemiology of Spina Bifida in a National Cohort from Denmark with a Comparison to Sweden. 61
29487873 2018
438
Analysis of Denver Neurodevelopmental Screening Test Results of Myelomeningocele, Hydrocephalus, and Microcephaly Patients. 61
29899768 2018
439
A novel proximal 3q29 chromosome microdeletion in a Chinese patient with Chiari malformation type II and Sprengel's deformity. 61
29410707 2018
440
[Fetal surgery for myelomeningocele: Obstetric evolution and short-term perinatal outcomes of a cohort of 21 cases]. 61
30595963 2018
441
Intradural spine surgery may not carry an increased risk of shunt revision compared with extradural spine surgery in pediatric patients with myelomeningocele. 61
29053056 2018
442
Myelomeningocele with Unilateral Right Renal Agenesis: A Case Report. 61
29321944 2018
443
Rare Giant Prevertebral Thoracic Myelomeningocele. 61
29042329 2018
444
Tocolysis for in utero Surgery: Atosiban Performs Distinctly Better than Magnesium Sulfate. 61
28813702 2018
445
Ultrasound guided transversus abdominis plane block. Postoperative analgesia in children with spinal dysraphism. 61
29332115 2018
446
Complete Reversibility of the Chiari Type II Malformation After Postnatal Repair of Myelomeningocele. 61
28867320 2017
447
Pre-operative risk factors for stomal stenosis with Malone antegrade continence enema procedures. 61
29248276 2017
448
A case of Wohlfahrtiimonas chitiniclastica bacteremia in continental United States. 61
29568530 2017
449
Management of urinary tract infection with intravesical amikacin may increase the risk of bladder oxidative stress in children with neurogenic bladder. 61
28956280 2017
450
Fetal surgery for myelomeningocele: After the Management of Myelomeningocele Study (MOMS). 61
29031539 2017
451
Early postnatal bladder function in fetoscopic myelomeningocele repair patients. 61
29125525 2017
452
First Case of Autonomic Dysreflexia Following Elective Lower Thoracic Spinal Cord Transection in a Spina Bifida Adult. 61
28782691 2017
453
Urologic self-management through intermittent self-catheterization among individuals with spina bifida: A journey to self-efficacy and autonomy. 61
29125508 2017
454
Variation in surgical management of neurogenic bowel among centers participating in National Spina Bifida Patient Registry. 61
29125521 2017
455
Variation in bowel and bladder continence across US spina bifida programs: A descriptive study. 61
29125511 2017
456
Bowel management and continence in adults with spina bifida: Results from the National Spina Bifida Patient Registry 2009-15. 61
29125526 2017
457
Crowdsourcing utility estimation for spina bifida in the general population. 61
29125514 2017
458
Prenatal congenital vertical talus (rocker bottom foot): a marker for multisystem anomalies. 61
28879597 2017
459
[INSPIRATORY STRIDOR OF A NON-TRADITIONAL CAUSE]. 61
29292618 2017
460
Advanced skeletal maturity in children and adolescents with myelomeningocele. 61
29125519 2017
461
Health-related quality of life in non-paraplegic (ambulatory) children with myelomeningocele. 61
28656385 2017
462
Amniotic fluid transcriptomics reflects novel disease mechanisms in fetuses with myelomeningocele. 61
28735706 2017
463
A comparison of three methods of measuring tibial torsion in children with myelomeningocele and normally developing children. 61
28470694 2017
464
Infant hydrocephalus in sub-Saharan Africa: the reality on the Tanzanian side of the lake. 61
28885096 2017
465
The management of paediatric neurogenic bladder: an approach in a resource-poor setting. 61
28714784 2017
466
Evolution of posterior fossa and brain morphology after in utero repair of open neural tube defects assessed by MRI. 61
28500367 2017
467
Mutations in folate transporter genes and risk for human myelomeningocele. 61
28948692 2017
468
Paper #20: Vertebral Column Resection for Early-Onset Scoliosis: Indications, Utilization and Outcomes. 61
31997190 2017
469
Long-term evaluation of intraoperative neurophysiological monitoring-assisted tethered cord surgery. 61
28676974 2017
470
Paper #45: Development of a Risk Severity Score (RSS) Predicting Surgical Site Infection in Early Onset Scoliosis: Identifying High-Risk Patients. 61
31997165 2017
471
Fetal surgical repair with placenta-derived mesenchymal stromal cell engineered patch in a rodent model of myelomeningocele. 61
29096888 2017
472
Ultrasound functional evaluation of fetuses with myelomeningocele: study of the interpretation of results. 61
27997256 2017
473
3q29 Chromosomal duplication in a neonate with associated myelomeningocele and midline cranial defects. 61
28763312 2017
474
In utero repair of fetal rat myelomeningocele affects neuromuscular development in the bladder. 61
29042964 2017
475
Histological evidence of reparative activity in chorioamniotic membrane following open fetal surgery for myelomeningocele. 61
29042971 2017
476
Bowel preparation prior to reconstructive urologic surgery in pediatric myelomeningocele patients. 61
28971794 2017
477
Placental mesenchymal stromal cells seeded on clinical grade extracellular matrix improve ambulation in ovine myelomeningocele. 61
29122293 2017
478
The antenatal urinary tract dilation classification system accurately predicts severity of kidney and urinary tract abnormalities. 61
28499796 2017
479
New device for intermittent emptying of the bladder in female children and adolescents: A pilot study. 61
28254445 2017
480
Robotic-assisted laparoscopic artificial urinary sphincter and MACE procedure on a pediatric patient. 61
28743562 2017
481
DiGeorge Syndrome with Sacral Myelomeningocele and Epilepsy. 61
29675073 2017
482
A Case of Fatal Pulmonary Hypoplasia with Congenital Diaphragmatic Hernia, Thoracic Myelomeningocele, and Thoracic Dysplasia. 61
29302380 2017
483
Systematic review of bladder cancer outcomes in patients with spina bifida. 61
28687411 2017
484
Theory of mind in spina bifida: Relationship with intellectual and executive functioning. 61
28901576 2017
485
Total endoscopic and anal irrigation management approach to noncompliant neuropathic bladder and bowel in children: A long-term follow-up. 61
29118540 2017
486
Congenital high airway obstruction syndrome (CHAOS) associated with cervical myelomeningocele. 61
27874207 2017
487
Functional Independence of Children With Myelomeningocele: Is It Associated With the Informal Caregivers' Burden? 61
28888508 2017
488
Physician views regarding the benefits and burdens of prenatal surgery for myelomeningocele. 61
28617430 2017
489
Endoscopic Third Ventriculostomy for the Treatment of Hydrocephalus in a Pediatric Population with Myelomeningocele. 61
28559064 2017
490
Committee Opinion No. 720 Summary: Maternal-Fetal Surgery for Myelomeningocele. 61
28832482 2017
491
Committee Opinion No. 720: Maternal-Fetal Surgery for Myelomeningocele. 61
28832491 2017
492
Neural tube defects in Waardenburg syndrome: A case report and review of the literature. 61
28686331 2017
493
The relationship between motor function, cognition, independence and quality of life in myelomeningocele patients. 61
28813080 2017
494
Tibial derotational osteotomies in two neuromuscular populations: comparing cerebral palsy with myelomeningocele. 61
28904628 2017
495
Mastery motivation and executive functions as predictors of adaptive behavior in adolescents and young adults with cerebral palsy or myelomeningocele. 61
28569523 2017
496
Spinal Shortening for Recurrent Tethered Cord Syndrome via a Lateral Retropleural Approach: A Novel Operative Technique. 61
29104840 2017
497
Changes in Management of Poorly Compliant Bladder in Botulinum Toxin A Era. 61
28689244 2017
498
Long-term results of fibular-Achilles tenodesis (Westin's tenodesis) for paralytic pes calcaneus: is hypercorrection avoidable? A longitudinal retrospective study. 61
28512689 2017
499
Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity. 61
28716326 2017
500
[Advances in fetal surgery]. 61
28850156 2017
501
Attention lapses in children with spina bifida and hydrocephalus and children with attention-deficit/hyperactivity disorder. 61
27868580 2017
502
Lipomyelomeningocele for the urologist: Should we view it the same as myelomeningocele? 61
28583853 2017
503
Health self-management, transition readiness and adaptive behavior in persons with cerebral palsy or myelomeningocele. 61
28836807 2017
504
Evaluation and Lifetime Management of the Urinary Tract in Patients with Myelomeningocele. 61
28716320 2017
505
Predictors of permanent disability among adults with spinal dysraphism. 61
28548634 2017
506
Agreement between electronic medical records and self-reported urologic domains in the National Spina Bifida Patient Registry (NSBPR): Implications for future research. 61
28655526 2017
507
Maternal-fetal surgery for myelomeningocele: some thoughts on ethical, legal, and psychological issues in a Western European situation. 61
28536839 2017
508
Prenatal myelomeningocele repair: Do bladders better? 61
27862250 2017
509
The surgical treatment of spinal deformity in children with myelomeningocele: the role of personalized three-dimensional printed models. 61
27902634 2017
510
First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt). 61
28470384 2017
511
Neurologic Decline in an Older Patient with Repaired Myelomeningocele Complicated with Lumbar Canal Stenosis. 61
28433844 2017
512
Antenatal management of fetal neurosurgical diseases. 61
28555310 2017
513
Fetoscopic patch coverage of experimental myelomenigocele using a two-port access in fetal sheep. 61
28550526 2017
514
Early treatment improves urodynamic prognosis in neurogenic voiding dysfunction: 20 years of experience. 61
28431215 2017
515
Isolation, characterization, and differentiation of multipotent neural progenitor cells from human cerebrospinal fluid in fetal cystic myelomeningocele. 61
28578005 2017
516
Sonographic detection of open spina bifida in the first trimester: review of the literature. 61
28510070 2017
517
The role of intrauterine magnetic resonance in the management of myelomenigocele. 61
28516216 2017
518
Spina Bifida Management. 61
28734746 2017
519
New directions in fetal surgery for myelomeningocele. 61
28497181 2017
520
Anesthesia for myelomeningocele surgery in fetus. 61
28547209 2017
521
Comparison of Prenatal and Postnatal Management of Patients with Myelomeningocele. 61
28600017 2017
522
Scoliosis in myelomeningocele: epidemiology, management, and functional outcome. 61
28452655 2017
523
Prenatal surgery for myelomeningocele: review of the literature and future directions. 61
28516217 2017
524
Surgical techniques for open fetal repair of myelomeningocele. 61
28510071 2017
525
Walking activity during daily living in children with myelomeningocele. 61
27384911 2017
526
Pregnancy and delivery after myelomeningocele repair, ventriculoperitoneal shunt implantation, and augmentation cystoplasty. 61
28247115 2017
527
A 4-Year Prospective Urological Assessment of In Utero Myelomeningocele Repair-Does Gestational Age at Birth Have a Role in Later Neurogenic Bladder Pattern? 61
27988193 2017
528
Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients. 61
28673062 2017
529
Delayed expansion of an intracranial cyst induced by ventriculoperitoneal shunt in a patient with Chiari malformation type 2. 61
28196729 2017
530
Closure of Meningomyelocele Defects With Sensate Medial Dorsal Intercostal Artery Perforator Flaps. 61
27801701 2017
531
Associations between post translational histone modifications, myelomeningocele risk, environmental arsenic exposure, and folate deficiency among participants in a case control study in Bangladesh. 61
28387569 2017
532
Surveillance survey of family history in children with neural tube defects. 61
28362184 2017
533
Diagnostic value of ultrasonography in spinal abnormalities among children with neurogenic bladder. 61
28848632 2017
534
Spinal column shortening for tethered cord syndrome associated with myelomeningocele, lumbosacral lipoma, and lipomyelomeningocele in children and young adults. 61
28362188 2017
535
Initial urological evaluation and management of children with neurogenic bladder due to myelomeningocele. 61
28215830 2017
536
Fetal Therapy Model of Myelomeningocele with Three-Dimensional Skin Using Amniotic Fluid Cell-Derived Induced Pluripotent Stem Cells. 61
28591652 2017
537
Bladder perforation after augmentation cystoplasty: Determining the best management option. 61
28262538 2017
538
Fetal Pathology of Neural Tube Defects - An Overview of 68 Cases. 61
28579621 2017
539
Urological Outcomes of Myelomeningocele and Lipomeningocele. 61
28285380 2017
540
Cognitive control and associated neural correlates in adults with spina bifida myelomeningocele. 61
28206781 2017
541
Is it the Monster "Teratoma" or Simply Meningomyelocele: Our Experience of "Histological Surprise". 61
28904585 2017
542
Pediatric Hydrocephalus in Ethiopia: Treatment Failures and Infections: A Hospital-Based, Retrospective Study. 61
28057596 2017
543
Split Notochord Syndrome: A Rare Variant. 61
28904581 2017
544
A combined surveillance program and quality register improves management of childhood disability. 61
27044661 2017
545
Morbidity associated with 30-day surgical site infection following nonshunt pediatric neurosurgery. 61
28186474 2017
546
Risk factors for surgical site infection following nonshunt pediatric neurosurgery: a review of 9296 procedures from a national database and comparison with a single-center experience. 61
28186476 2017
547
A comparison of the MOMS trial results to a contemporaneous, single-institution, postnatal closure cohort. 61
28028598 2017
548
The current profile of persistent cloaca and cloacal exstrophy in Japan: the results of a nationwide survey in 2014 and a review of the literature. 61
28058485 2017
549
Fetal surgery: a critical review. 61
28058487 2017
550
Managing fecal incontinence in patients with myelomeningocele in Sub-Saharan Africa: Role of antegrade continence enema (ACE). 61
27634558 2017
551
Management and Outcome of Infantile Hydrocephalus in a Tertiary Health Institution in Nigeria. 61
28479801 2017
552
Fetoscopic Open Neural Tube Defect Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. 61
28277363 2017
553
Fasting serum blood measures of bone and lipid metabolism in children with myelomeningocele for early detection of cardiovascular and bone fragility risk factors. 61
26666357 2017
554
Conventional physical therapy and physical therapy based on reflex stimulation showed similar results in children with myelomeningocele. 61
28355323 2017
555
Effectiveness of the Ponseti method for treating clubfoot associated with myelomeningocele: 3-9 years follow-up. 61
27386794 2017
556
Long-term follow-up of superior gluteal artery perforator flap closure of large myelomeningoceles. 61
28106513 2017
557
Hemimetameric shift in spina bifida: three case reports. 61
27822764 2017
558
The intersection of fetal palliative care and fetal surgery: Addressing mortality and quality of life. 61
28108023 2017
559
Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida: A systematic review. 61
27187872 2017
560
Associated anomalies and clinical outcome in children with ectopic kidney. 61
28352016 2017
561
Determination of the Effect of Diameter of the Sac on Prognosis in 64 Cases Operated for Meningomyelocele. 61
28407703 2017
562
Rehabilitation of children and adolescents with myelomeningocele: the daily life of mothers-caregiversRehabilitation of children and adolescents with myelomeningocele: the daily life of mothers-caregivers. 61
28198945 2017
563
Correlation of mortality with lesion level in patients with myelomeningocele: a population-based study. 61
27911247 2017
564
Fetal surgery for myelomeningocele: current clinical practice and translational research. 61
27830929 2017
565
Cystatin C-calculated Glomerular Filtration Rate-A Marker of Early Renal Dysfunction in Patients With Neuropathic Bladder. 61
27542858 2017
566
Early numeracy skills in preschool-aged children: a review of neurocognitive findings and implications for assessment and intervention. 61
27875931 2017
567
Neonatal Hospital Course and Outcomes of Live-born Infants with Trisomy 18 at Two Tertiary Care Centers in the United States. 61
27490773 2017
568
Ten-year survival of Ugandan infants after myelomeningocele closure. 61
27767901 2017
569
Effect of Orthotic Gait Training with Isocentric Reciprocating Gait Orthosis on Walking in Children with Myelomeningocele. 61
29339891 2017
570
Reliability of extended dorsal intercostal artery perforator propeller flaps for reconstruction of large myelomeningocele defects. 61
27894916 2017
571
Maternal gene-micronutrient interactions related to one-carbon metabolism and the risk of myelomeningocele among offspring. 61
27384413 2017
572
Methotrexate and Valproic Acid Affect Early Neurogenesis of Human Amniotic Fluid Stem Cells from Myelomeningocele. 61
29056972 2017
573
Current views on fetal surgical treatment of myelomeningocele - the Management of Myelomeningocele Study (MOMS) trial and Polish clinical experience. 61
28157255 2017
574
The mortality rate after hospital discharge in patients with myelomeningocele decreased after implementation of mandatory flour fortification with folic acid. 61
28099558 2017
575
Third Ventricle Floor Variations and Abnormalities in Myelomeningocele-Associated Hydrocephalus: Our Experience with 455 Endoscopic Third Ventriculostomy Procedures. 61
27858385 2017
576
Exploring the Pharmacokinetic Profile of Remifentanil in Mid-Trimester Gestations Undergoing Fetal Intervention Procedures. 61
28174536 2017
577
Left-colon antegrade enema (LACE): Long-term experience with the Macedo-Malone approach. 61
26417710 2017
578
Limited Dorsal Myeloschisis: A Diagnostic Pitfall in the Prenatal Ultrasound of Fetal Dysraphism. 61
27160821 2017
579
Dermoid of the Posterior Fossa in Chiari II Malformation: The First Reported Case. 61
28553378 2017
580
Specialty-Based Variation in Applying Maternal-Fetal Surgery Trial Evidence. 61
28301843 2017
581
Visceral Hyperalgesia: When to Consider Gabapentin Use in Neonates-Case Study and Review. 61
28503628 2017
582
Tethered cord syndrome with spina bifida aperta in cats: two case reports of different types. 61
28546867 2017
583
The Prevalence and Distribution of Spina Bifida in a Single Major Referral Center in Malaysia. 61
29170734 2017
584
Prenatal Sacral Anomalies Leading to the Detection of Associated Spinal Cord Malformations. 61
28463829 2017
585
Lipoencephalocele in a Child: An Uncommon Swelling in the Occipital Region. 61
28668954 2017
586
Prenatal folic acid use associated with decreased risk of myelomeningocele: A case-control study offers further support for folic acid fortification in Bangladesh. 61
29190654 2017
587
Spinal cordectomy: A new hope for morbid spinal conditions. 61
27846400 2017
588
Clusters of amniotic fluid cells and their associated early neuroepithelial markers in experimental myelomeningocele: Correlation with astrogliosis. 61
28358903 2017
589
Long-term mortality rates in pediatric hydrocephalus-a retrospective single-center study. 61
27766469 2017
590
Fetal Myelomeningocele Repair through a Mini-Hysterotomy. 61
27656888 2017
591
Establishing Prenatal Surgery for Myelomeningocele in Asia: The Singapore Consensus. 61
28219061 2017
592
Myelomeningocele Repair: Surgical Management Based on a 30-Year Experience. 61
28120066 2017
593
Distribution of interstitial cells of Cajal in the bladders of fetal rats with retinoic acid induced myelomeningocele. 61
27909623 2016
594
Closure of a Large Thoracolumbar Myelomeningocele Using a Modified Bilateral Keystone Flap. 61
28293496 2016
595
Spinal cord anomalies in patients with anorectal malformations without severe sacral abnormalities or meningomyelocele: outcomes after expectant, conservative management. 61
27448173 2016
596
Incidence of Hip Dysplasia Associated With Bladder Exstrophy. 61
26090968 2016
597
Right-Sided Congenital Diaphragmatic Hernia and Myelomeningocele: A Rare Association. 61
28043315 2016
598
What is the outcome of paediatric gastrocystoplasty when the patients reach adulthood? 61
27322857 2016
599
Urological Outcome of the Xiao Procedure in Children with Myelomeningocele and Lipomyelomeningocele Undergoing Spinal Cord Detethering. 61
27288694 2016
600
The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. 61
27496687 2016
601
Long-term outcomes of the Kropp and Salle urethral lengthening bladder neck reconstruction procedures. 61
27687531 2016
602
Use of dermal regeneration template to close a giant myelomeningocele in a newborn. 61
27503247 2016
603
An Ideal Flap Alternative for Closure of Myelomeningocele Defects: Dorsal Intercostal Artery Perforator Flap. 61
28005733 2016
604
Tetanus and Occam's Razor: Almost Forgotten but Not Gone: A Case Report. 61
27940761 2016
605
Paralympic athletes' perceptions of their experiences of sports-related injuries, risk factors and preventive possibilities. 61
27329262 2016
606
Transcranial Doppler in the evaluation of infants treated with retrograde ventriculosinus shunt. 61
27638718 2016
607
Predicting ventriculoperitoneal shunt infection in children with hydrocephalus using artificial neural network. 61
27638720 2016
608
Intermittent urethral catheterisation: the reality of the lubricants and catheters in the clinical practice of a Brazilian service. 61
27378618 2016
609
Alobar Holoprosencephaly Associated with Meningomyelocoele and Omphalocoele: An Unusual Coexistence. 61
28050387 2016
610
Fetal Myelomeningocele After Maternal Methotrexate Administration: A Case Report. 61
30230290 2016
611
[Latex allergy in a paediatric hospital. Characteristics and risk factors]. 61
27354157 2016
612
Research: Prevalence of neural tube defects Khartoum, Sudan August 2014-July 2015. 61
27881182 2016
613
Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele. 61
27798984 2016
614
Survey on Current Postnatal Surgical Management of Myelomeningocele in Germany. 61
27273605 2016
615
G6PD Deficiency with Arnold-Chiari Malformation. 61
27981932 2016
616
The impact of mode of delivery on infant neurologic outcomes in myelomeningocele. 61
27242203 2016
617
Thirty-day outcomes after postnatal myelomeningocele repair: a National Surgical Quality Improvement Program Pediatric database analysis. 61
27258591 2016
618
Robotic-assisted laparoscopic bladder augmentation in the pediatric patient. 61
27687533 2016
619
Advances in fetal surgery. 61
27867946 2016
620
Association between clean intermittent catheterization and urinary tract infection in infants and toddlers with spina bifida. 61
27118581 2016
621
Prenatal diagnosis of tethered spinal cord associated with sacrococcygeal teratoma. 61
26892808 2016
622
Early onset scoliosis with intraspinal anomalies: management with growing rod. 61
27072552 2016
623
Genetic association of the glycine cleavage system genes and myelomeningocele. 61
27620832 2016
624
Impact on family and parental stress of prenatal vs postnatal repair of myelomeningocele. 61
27263997 2016
625
Cervical myelomeningocele associated with multiple spinal anomalies. 61
26994553 2016
626
Can We Further Improve the Quality of Nephro-Urological Care in Children with Myelomeningocele? 61
27598183 2016
627
[Quality of Life and Satisfaction in Patients and Families with Myelomeningocele]. 61
27605474 2016
628
Amniotic fluid levels of phospholipase A2 in fetal rats with retinoic acid induced myelomeningocele: the potential "second hit" in neurologic damage. 61
26513600 2016
629
Bowel perforation presenting with acute abdominal pain and subcutaneous emphysema in a 14-year-old girl with an abandoned distal peritoneal shunt catheter: case report. 61
27153375 2016
630
Cervicothoracic cystic dysraphism. 61
27147079 2016
631
Risk factors for unplanned readmission within 30 days after pediatric neurosurgery: a nationwide analysis of 9799 procedures from the American College of Surgeons National Surgical Quality Improvement Program. 61
27184348 2016
632
A rare cause of gluteal swelling: lateral sacral meningomyelocele. 61
26921628 2016
633
Infection rate correlated with time to repair of open neural tube defects (myelomeningoceles): an institutional and national study. 61
27444296 2016
634
Profiles of Neuropsychological Functioning in Children and Adolescents with Spina Bifida: Associations with Biopsychosocial Predictors and Functional Outcomes. 61
27573527 2016
635
An Application of Keystone Perforator Island Flap for Closure of Lumbosacral Myelomeningocele Defects. 61
26418773 2016
636
Health-related quality of life in children with myelomeningocele: a systematic review of the literature. 61
27381478 2016
637
Sacral agenesis: evaluation of accompanying pathologies in 38 cases, with analysis of long-term outcomes. 61
26872465 2016
638
Stem Cells in Functional Bladder Engineering. 61
27781020 2016
639
Latex sensitization in patients with myelomeningocele undergoing urological procedures: prevalence and associated factors. 61
27033690 2016
640
A decision-making guide for the closure of myelomeningocele skin defects with or without primary repair. 61
27104629 2016
641
Fetal Central Nervous System Anomalies Detected by Magnetic Resonance Imaging: A Two-Year Experience. 61
27729957 2016
642
Procedure-related complications of open vs endoscopic fetal surgery for treatment of spina bifida in an era of intrauterine myelomeningocele repair: systematic review and meta-analysis. 61
26612040 2016
643
Factors associated with the timeliness of postnatal surgical repair of spina bifida. 61
27179533 2016
644
Communication about maternal-fetal surgery for myelomeningocele and congenital diaphragmatic hernia: preliminary findings with implications for informed consent and shared decision-making. 61
25870957 2016
645
Variation in Outcome in Tethered Cord Syndrome. 61
27559452 2016
646
Outcome of Endoscopic Third Ventriculostomy in Pediatric Patients at Zewditu Memorial Hospital, Ethiopia. 61
27157284 2016
647
Outcomes of infants followed-up at least 12 months after fetal open and endoscopic surgery for meningomyelocele: a systematic review and meta-analysis. 61
27305320 2016
648
Lack of efficacy of an intradural somatic-to-autonomic nerve anastomosis (Xiao procedure) for bladder control in children with myelomeningocele and lipomyelomeningocele: results of a prospective, randomized, double-blind study. 61
27137626 2016
649
Bilateral Femoral Fracture in a newborn with Myelomeningocele at Cesarean section: A Case Report. 61
28116279 2016
650
Quantitative Analysis of Lower Leg Adipose Tissue Distribution in Youth with Myelomeningocele. 61
26961265 2016
651
Intradural teratoma in a neonate with meningomyelocele. 61
27366286 2016
652
Pneumocephalus in Child Following Bilateral Otomastoiditis and Nasal Septum Infection. 61
27504559 2016
653
Managing adult urinary incontinence from the congenitally incompetent bladder outlet. 61
27096718 2016
654
[Simultaneous diagnosis of pseudomeningocele, tethered cord syndrome and cerebrospinal fluid fistula: Report of a case]. 61
26936617 2016
655
High-Dose Desflurane for Tocolysis During Intrapartum Myelomeningocele Repair in a Patient With Post-Adriamycin Cardiomyopathy. 61
27182782 2016
656
Trends in epidemiology and hospitalization utilization for myelomeningocele repair from 2000 to 2009. 61
27112355 2016
657
Myelomeningocele - a single institute analysis of the years 2007 to 2015. 61
27086130 2016
658
[Spondylocostal dysostosis and acute cholangitis in pediatrics emergency room]. 61
29421389 2016
659
Adults with myelomeningocele and other forms of spinal dysraphism: hospital care in the United States since the turn of the millennium. 61
26926705 2016
660
Fertility and sexual dysfunction issues in adults with genitourinary congenital anomalies. 61
27139192 2016
661
Five-Level Posterior Total En Bloc Spondylectomy of Severe Myelomeningocele Kyphosis. 61
26975984 2016
662
Comparison of the microbiological milieu of patients randomized to either hydrophilic or conventional PVC catheters for clean intermittent catheterization. 61
26951923 2016
663
Sequential morphological change of Chiari malformation type II following surgical repair of myelomeningocele. 61
26936599 2016
664
Footloose: Spinal Myoclonus after Myelomeningocele Repair. 61
26968832 2016
665
Surgical Management of Hip Problems in Myelomeningocele: A Review Article. 61
27517062 2016
666
Versatility of V-Y Flap in Gluteal Area. 61
27579271 2016
667
Facilitating triple rhomboid flaps for meningomyelocele defect closure using a honeycomb structure as a template. 61
26875083 2016
668
Gray matter integrity within regions of the dorsolateral prefrontal cortical-subcortical network predicts executive function and fine motor dexterity in spina bifida. 61
26752120 2016
669
Kyphectomy in Children With Severe Myelomeningocele-Related Kyphosis. 61
27927508 2016
670
Chorioamniotic membrane separation and preterm premature rupture of membranes complicating in utero myelomeningocele repair. 61
26692177 2016
671
Dorsal Intercostal Artery Perforator Propeller Flaps: A Reliable Option in Reconstruction of Large Meningomyelocele Defects. 61
26010351 2016
672
Plasticity of Interhemispheric Temporal Lobe White Matter Pathways Due to Early Disruption of Corpus Callosum Development in Spina Bifida. 61
26798959 2016
673
Short-term prognostic factors in myelomeningocele patients. 61
26753898 2016
674
Novel Concepts in Spine Pathophysiology. 61
27015066 2016
675
Prenatal surgery for myelomeningocele. 61
26866841 2016
676
[Urodynamic changes after bladder augmentation surgery in paediatric patients with myelomeningocele due to neurogenic bladder]. 61
26707251 2016
677
Role of Endoscopic Third Ventriculostomy in the Management of Myelomeningocele-Related Hydrocephalus: A Retrospective Study in a Single French Institution. 61
26278870 2016
678
Early management of neurologic clubfoot using Ponseti casting with minor posterior release in myelomeningocele: a preliminary report. 61
26426504 2016
679
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging of squamous cell carcinoma arising in a meningomyelocele. 61
26701228 2016
680
Resolution of septic shock in a patient with myelomeningocele (spina bifida) complicated with deforming Elephantiasis Nostras Verrucosa. 61
25623264 2016
681
White and grey matter relations to simple, choice, and cognitive reaction time in spina bifida. 61
26040977 2016
682
Spina Bifida, Meningomyelocele, and Meningocele. 61
26725976 2016
683
Parasitic twin--a supernumerary limb associated with spinal malformations. A case report. 61
26811301 2016
684
Current Selection Criteria and Perioperative Therapy Used for Fetal Myelomeningocele Surgery. 61
26855109 2016
685
Prenatal ultrasound evaluation of segmental level of neurological lesion in fetuses with myelomeningocele: development of a new technique. 61
26306897 2016
686
Re: Prenatal ultrasound evaluation of segmental level of neurological lesion in fetuses with myelomeningocele: development of a new technique. E.Carreras, A. Maroto, T. Illescas, M. Meléndez, S. Arévalo, J. L. Peiró, C. G. García-Fontecha, M. Belfort and A. Cuxart. Ultrasound Obstet Gynecol 2016; 47: 162-167. 61
26833638 2016
687
Long-term neurofunctional outcome, executive functioning, and behavioral adaptive skills following fetal myelomeningocele surgery. 61
26440692 2016
688
Prevalence of latex allergy in a population of patients diagnosed with myelomeningocele. 61
26914072 2016
689
Long-standing meningomyelocele can be a predictor of difficult airway and postoperative hypoventilation: challenge to the anaesthesiologist. 61
26884079 2016
690
Management options for sphincteric deficiency in adults with neurogenic bladder. 61
26904420 2016
691
Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity. 61
25524826 2016
692
[CYSTECTASY AND REHABILITATION TRAINING FOR TREATMENT OF NEUROGENIC BLADDER DYSFUNCTION WITH HYPERREFLEXIA]. 61
27276820 2016
693
Percutaneous minimally invasive fetoscopic surgery for spina bifida aperta. Part III: neurosurgical intervention in the first postnatal year. 61
26138563 2016
694
Associated congenital anomalies in infants with isolated gastroschisis: A single-institutional experience. 61
26464049 2016
695
Endoscopic third ventriculostomy and choroid plexus cauterization with a rigid neuroendoscope in infants with hydrocephalus. 61
26517057 2016
696
Closure of Myelomeningocele Defects Using a Limberg Flap or Direct Repair. 61
26848442 2016
697
Bone Mineral Content in Infants With Myelomeningocele, With and Without Treadmill Stepping Practice. 61
27088680 2016
698
Commentary on "Bone Mineral Content in Infants With Myelomeningocele, With and Without Treadmill Stepping Practice". 61
27088681 2016
699
A rare case of giant multiseptated thoracic myelomeningocele with segmental placode: Commentary. 61
27274401 2016
700
Fetal surgery and maternal cortisol response to stress. The myelomeningocele sheep model. 61
25708491 2016
701
Fetal Heart Rate Monitoring during Intrauterine Open Surgery for Myelomeningocele Repair. 61
26304733 2016
702
Neurosurgery concepts: Key perspectives on intrathecal fluorescein for detecting intraoperative cerebrospinal fluid leak during endoscopic endonasal surgery, spinal intraarterial chemotherapy, oligoastrocytoma classification by in situ molecular genetics, and prenatal myelomeningocele closure and the need for cerebrospinal fluid shunt placement. 61
27857862 2016
703
Age Does Matter: A Pilot Comparison of Placenta-Derived Stromal Cells for in utero Repair of Myelomeningocele Using a Lamb Model. 61
26159889 2016
704
The Management of the Pediatric Neurogenic Bladder. 61
27610207 2016
705
Bilateral Rib-Based Distraction to the Pelvis for the Management of Congenital Gibbus Deformity in the Growing Child With Myelodysplasia. 61
27852504 2016
706
Children with special health needs and family: implications for Nursing. 61
26871220 2016
707
[Surgical treatment outcomes in children with tethered spinal cord syndrome. A prognosis on the basis of spinal 3T MRI tractography]. 61
27296539 2016
708
The Prevalence of MRSA Nasal Carriage in Preoperative Pediatric Orthopaedic Patients. 61
27688914 2016
709
Perinatal and Neonatal Outcomes of Patients Who Were Diagnosed with Neural Tube Defect in Midtrimester Fetal Ultrasound Scan and Refused Request for Termination of Pregnancy. 61
27999804 2016
710
[Impact of low level laser therapy on skin blood flow]. 61
27416624 2016
711
Bone mineral density in pediatric patients with meningomyelocele. 61
26471372 2016
712
Magnesium-permeable TRPM6 polymorphisms in patients with meningomyelocele. 61
27757375 2016
713
Lateral Meningomyelocele in a Neonate: A Case Report. 61
26793596 2016
714
Amenorrhea after Endoscopic Third Ventriculostomy for a Failed Shunt in Spina Bifida: Case Report and Review of the Literature. 61
26550836 2016
715
Fetoscopic versus Open Repair for Spina Bifida Aperta: A Systematic Review of Outcomes. 61
26901156 2016
716
Current Management Strategies of Hydrocephalus in the Child With Open Spina Bifida. 61
29339864 2016
717
Tetrasomy 18p in a Twin Pregnancy with Diverse Expression in Both Fetuses. 61
27309155 2016
718
Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature. 61
27795884 2016
719
Triploidy: Variation of Phenotype. 61
26712875 2016
720
Methylome analysis for spina bifida shows SOX18 hypomethylation as a risk factor with evidence for a complex (epi)genetic interplay to affect neural tube development. 61
27757173 2016
721
Contiguous triple spinal dysraphism associated with Chiari malformation Type II and hydrocephalus: an embryological conundrum between the unified theory of Pang and the unified theory of McLone. 61
26474100 2016
722
Anesthetic Challenges and Management in a case of Jarcho-Levin Syndrome with a Neural Tube Defect in a Newborn. 61
29164846 2016
723
Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil. 61
26769993 2016
724
Diagnostic value of CA 19-9 in pregnancies complicated by spinal neural tube defects: a preliminary study. 61
28098931 2016
725
Maternal serum vitamin D levels in pregnancies complicated by neural tube defects. 61
25544605 2016
726
Pleuropulmonary Blastoma in a Neonate Diagnosed Prenatally as Congenital Pulmonary Airway Malformation. 61
26227654 2016
727
[Respiratory complications in children with Chiari malformation type II associated with myelomeningocele]. 61
27012106 2016
728
Endoscopic surgery for the antenatal treatment of myelomeningocele: the CECAM trial. 61
26386383 2016
729
Complications after bladder augmentation in children. 61
27142898 2016
730
Complete tissue coverage achieved by scaffold-based tissue engineering in the fetal sheep model of Myelomeningocele. 61
26520044 2016
731
Rigid Instrumentation for Neuromuscular Scoliosis Improves Deformity Correction Without Increasing Complications. 61
26352742 2016
732
Fetal Heart Rate during in Utero Myelomeningocele Repair: Effect of Anesthesia and Analgesia. 61
27509040 2016
733
Management of Lumbosacral Myelomeningocele. 61
28090243 2016
734
Response of Scoliosis in Children with Myelomeningocele to Surgical Release of Tethered Spinal Cord. 61
29339865 2016
735
Surgical technique of retrograde ventricle-sinus shunt is an option for the treatment of hydrocephalus in infants after surgical repair of myelomeningocele. 61
26677123 2015
736
Safety and Efficacy of Apical Resection Following Growth-friendly Instrumentation in Myelomeningocele Patients With Gibbus: Growing Rod Versus Luque Trolley. 61
25705808 2015
737
Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. 61
26369371 2015
738
Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life. 61